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CHAPTER 1 INTRODUCTION
1.1 Summary
The long term goal of my thesis research is to understand how tissue-specific
phosphorylations on the small mitochondrial protein, cytochrome c (Cytc), regulate its
functions, under both physiologically healthy and stressed conditions, and to identify the
cell signaling pathways targeting Cytc. Cytc is a functionally diverse protein that carries
electrons in the electron transport chain and plays a critical role in cellular apoptosis, two
diverse pathways that maintain cellular health that are active under diverse conditions.
Since Cytc plays a pivotal role in both these highly divergent pathways, regulation of the
protein is very important—phosphorylation of the protein under physiological conditions
hence implies a regulation by cell signaling pathways that have yet to be identified and
studied. Previous work by our lab suggests the importance of reversible phosphorylation
of Cytc in regulating its functions

1-4.

We hypothesize that under healthy conditions,

phosphorylated Cytc partially inhibits mitochondrial respiration and maintains healthy
mitochondrial membrane potential, preventing ROS generation, while cellular stressmediated dephosphorylation leads to increased respiration and ROS generation, initiating
apoptosis. To further test this hypothesis and to extend our understanding of Cytc
phosphorylation on its functions, I conducted two studies. In the first study, I investigated
the physiological phosphorylation status of Cytc in mammalian kidney tissues. To begin
with, I purified bovine kidney Cytc in the presence of phosphatase inhibitors, identified
threonine phosphorylation by immunoblot analysis, and determined threonine 28
phosphorylation

by

immobilized

metal

affinity

chromatography/nano-liquid

chromatography/electrospray ionization mass spectrometry (Nano/LC/ESI/MS/MS). To
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characterize the effect of Thr28 phosphorylation on Cytc functions, I mutated Thr28 to
glutamate, a phosphomimetic mutation, and alanine, a nonphosphorylatable control. I
went on to express and purify wild-type, the phosphomimetic mutant and the nonphosphorylatable mutant Cytc in bacterial cells. I also expressed and analyzed wild-type,
the phosphomimetic mutant and the nonphosphorylatable mutant Cytc in mammalian
cells to determine the effects of the Cytc mutations on the functions of the protein in vitro
and on overall cellular metabolism and physiology, under healthy and stressed conditions.
I also found that Thr28 phosphorylation is AMP kinase-mediated, and AMP kinase
colocalizes with Cytc to the mitochondrial intermembrane space. Our data suggest that
Thr28, conserved in mammalian Cytc, is an important regulatory site that leads to
regulation of ETC flux via ‘controlled respiration,’ preventing m hyperpolarization, a
known cause of ROS and trigger of apoptosis (discussed in Chapter 2, manuscript under
preparation). In the second study, the phosphorylation status of Cytc in ischemic brain
was investigated to determine if insulin-induced neuroprotection and inhibition of Cytc
release in ischemic brain was associated with Cytc phosphorylation. We used an animal
model of global brain ischemia, and found a 50% decreased death rate of CA1
hippocampal neurons after neuroprotective post-ischemic insulin administration as
compared to untreated controls. The increased survival of CA1 neurons was correlated
to inhibition of Cytc release from mitochondria into cytosol 24 hours post reperfusion,
which in turn was mediated by Cytc phosphorylation on Tyr97. We thus propose that Cytc
is phosphorylated by an insulin-dependent signaling pathway, and this may impede with
its release from mitochondria and its ability to induce apoptosis (discussed in Chapter 3,
manuscript published in PLoS One, 2013 8(11):e78627).

3

1.2 Cytochrome c
Cytc is a small, 12.4 kDa globular protein localized in the mitochondrial
intermembrane space under healthy or unstressed condition. It is a hemoprotein, with the
heme group covalently linked to cysteines 14 and 17 of the peptide chain via thio-ether
bonds. The hexa-coordinated, low-spin iron in the heme group is coordinated by His18
and Met80 residues. The human Cytc protein is encoded by the nuclear gene, CYCS. [1][2]
Being a nuclear-encoded gene, Cytc is translated in the cytoplasm as apo-cytochrome c.
The heme group is attached to apo-cytochrome c upon its translocation to the
mitochondria. Under normal (i.e., non-apoptotic) conditions Cytc is located in the
intermembrane space of mitochondria, and is mostly associated with the outer surface of
the inner mitochondrial membrane by electrostatic and hydrophobic interactions with the
negatively charged phospholipids, in particular cardiolipin5.
Cytc is classified to the family of proteins containing covalently linked c-type
cytochromes. Unlike other cytochromes, it is a positively charged, highly water-soluble
protein, with a solubility approximately 100 g/L6. It is highly conserved across all species,
with its presence in plants, animals, and several unicellular organisms. With only a few
residues varying in mammals, it contains a highly conserved amino acid sequence. The
high level of conservation makes it an extensively studied protein over the years,
providing an insight into evolutionary biology. Studies of cytochrome c sequences
revealed that sequences from humans and chimpanzees, our closest relative, were
identical, whereas it was different from horses by 10 residues7.
Cytochrome c is an essential protein in the electron transport chain between
the quinol:cytochrome c oxidoreductase (complex III, or cytochrome bc1) and the
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cytochrome c oxidase (complex IV, CcO or cytochrome a/a3), where it is involved in the
generation of energy in the form of ATP. It is also one of the major players in intrinsic
mitochondrial apoptosis. Cytc can undergo oxidation and reduction, but it does not bind
oxygen. This feature is utilized in the oxidative phosphorylation process, where Cytc
accepts a single electron from coenzyme Q – cytochrome c reductase and donates it to
cytochrome c oxidase, the final electron acceptor that converts molecular oxygen to
water. The latter is the proposed rate limiting step of the ETC7. While its function as an
electron carrier is revealed under healthy cellular conditions, under stressed conditions,
cytochrome c unveils its role in the intrinsic mitochondrial apoptosis cascade, by being
released from the mitochondrial intermembrane space into the cytosol.
1.3 History of Cytochrome c
Microspectroscopic studies by C. S. McMunn (1852-1911) on tissue specimens
across various phylum, from coelenterates to man, lead to the origination of the idea that
heme proteins play a role in respiration. McMunn carefully removed blood from each
sample and found a pigment that displayed a common absorption spectrum, thereby
discovering cytochrome c in 1884. He termed the pigment myohaematin (in muscles) and
histohaematin (in other tissues). He demonstrated intensification of bands by reduction
and weakening by oxidation. Thus, he discovered a protein capable of redox functions in
vertebrates and invertebrate, and showed that the chemistry of energy production in the
body took place deep in the cellular structure of the tissues, and not just in the blood as
had been previously assumed. These respiratory pigments are now known as
cytochromes, and are fundamental to energy metabolism.
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David Keilin, a Polish parasitologist in Cambridge, rediscovered cytochromes
in 1925, and recognised MacMunn’s achievement by identifying their function in cellular
respiration 8. Keilin’s studies identified the same absorption bands identified by MacMunn
not only in the fly, but in Bacillus subtilis and in baker’s yeast. Keilin christened the
ubiquitous colored pigments cytochromes. Cytochromes were further classified by Keilin
by their lowest energy absorption band under reducing condition, naming them
cytochrome a (604nm), b (564nm) and c (550nm)8. Keilin laid out the basic picture of the
respiratory chain in the 1920’s. Due to the presence of an iron (Fe) atom in heme it was
believed that cytochrome c could act as an electron carrier by undergoing oxidation
reduction reactions.
1.4 Structure of cytochrome c
Horse heart Cytc was one of the first proteins to be crystallized. The c-type
cytochromes, among the best studied players in mitochondrial electron transport, contain
redox-active heme proteins for which X-ray crystallographic structures of Cytc revealed
that the heme group is covalently linked to the mature peptide chain of the protein (note
that the mature protein lacks the N-terminal methionine residue) by two thioether bonds
between the heme vinyls and cysteine residues 14 and 17 of the conserved heme-binding
motif on the protein9,10. The heme iron exists in a hexacoordinate configuration with the
His18 and Met80 residues acting as ligands. The heme iron-Met80 bond results in a weak
695 nm absorption band in the spectrum of oxidized Cytc, the lack of which indicates that
the protein is not correctly folded (Dickerson and Timkovich, 1975). Surrounded by
aliphatic and aromatic side chains, the heme group resides in a very hydrophobic
environment and this, together with the iron ligands His18 and Met80, provides an
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explanation for the high redox potential of Cytc (~260 mV in mammals) 4. Only 7.5% of
the heme surface remains exposed to the solvent
transfer electrons from complex III to complex IV

10,

and it is this site that is used to

11-14.

1.5 Cytochrome c is an essential protein
Murine embryos that are lacking Cytc die in utero by midgestation15. They show
a clearly evident and profound developmental delay at E8.5 and do not survive after stage
E10.5. However, cell lines established from early Cytc null embryos are viable under
conditions that compensate for defective oxidative phosphorylation, and they are resistant
to apoptosis via stimuli such as UV irradiation, serum starvation and staurosporine15, and
show reduced caspase-3 activity, but are highly sensitive to TNFα mediated cell-death
signals16,17. This is because the intrinsic Cytc-dependent apoptotic pathway remains
inactive, while the extrinsic apoptotic pathway remains active. Since the primary role of
Cytc is to carry electrons in the ETC, Cytc null cells suffer from a defective electron
transport and oxidative phosphorylation system, leading to early lethality of the embryos.
1.6 Functions of cytochrome c:
1.6.1 Role of cytochrome c in oxidative phosphorylation
Cytc is located in the mitochondrial intermembrane space, and in the terminal
step of the ETC, reduced Cytc carries a single electron from complex III to complex IV
(cytochrome c oxidase), which in turn oxidizes Cytc and reduces a single molecule of
oxygen to water on transfer of four such electrons. Under physiological conditions in intact
mitochondria, this is the rate-limiting step of the ETC 18-22. The irreversible conversion of
oxygen to water is accompanied by a free energy change of ΔGo’= -100 kJ/mol 23.
1.6.2 Cytochrome c and Erv1-Mia40-coupled protein import
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Cytc is synthesized from its nuclear gene as apocytochrome c, imported into
mitochondrial intermembrane space and is converted into the holo-form by the Cytc heme
lyase-catalyzed heme addition

24.

In the intermembrane space, it functions in the redox-

coupled protein import pathway along with the transporters of outer membrane (TOMs),
Erv1, and Mia40 proteins. Together, they import small transporters of inner membrane
(TIMs) and other proteins that contain the twin CX3C and CX9C motifs into the
intermembrane space 25. Then, these proteins undergo post-import modifications such as
alternative folding, and on being oxidized by Mia40, these proteins form disulfide bonds
between the cysteine residues that finally lock alter their tertiary structure

26.

Mia40 is

reactivated by Erv1-mediated oxidation, and Erv1 is reoxidized by Cytc 27. The electrons
that are sequentially transported from the imported protein to Mia40 to Erv1 to Cytc finally
feed into the ETC.
1.6.3 Role of cytochrome c as both a ROS scavenger and producer
A) During the transfer of electrons by the ETC complexes, redox intermediates
are generated mainly by complexes I and III and the reduced ubiquinol pool. These
intermediates can also take part in various side reactions and as a result, transfer
electrons directly to oxygen, generating ROS as a byproduct of the ETC

28,29.

The cells

are equipped with radical scavenging enzymes to neutralize ROS, such as superoxide
dismutase (SOD) and catalase. Cytc is constantly reduced by complex III and oxidized
by complex IV, and is thus capable of performing the functions of an antioxidant. Along
with SODs and catalase, Cytc also removes unpaired electrons from superoxides
generated in the intermembrane space, regenerating O2

30,31,

finally donating these

electrons to cytochrome c oxidase (COX). It also scavenges hydrogen peroxides

32.
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B) A splice variant of the growth factor adapter Shc, namely p66shc, is found
throughout the cell with a subset localizing to the mitochondria, where it affects
mitochondrial function

33.

Under stress conditions, mitochondrial p66shc is oxidized by

electrons supplied by Cytc, which leads to the p66shc-mediated production of hydrogen
peroxide 34. The increase in ROS production via p66shc as part of the apoptotic pathway
would provide Cytc with peroxide equivalents necessary for the oxidation of cardiolipin, a
process that is required for its release from the mitochondria as discussed below. Indeed,
release of Cytc correlates with the H2O2 production activity of p66shc

35,

and could be a

significant switch utilized by the cell as an initiating event of apoptosis.
1.6.4 Role of cytochrome c in apoptosis
Cytc plays an essential function in the induction of apoptosis, as was
established more than a decade ago

36,

and it is not degraded during apoptosis

37.

Thousands of studies have furthered this knowledge and now, the established model of
mitochondrial type II apoptosis considers Cytc release from mitochondria into the cytosol
and binding to apoptotic protease-activating factor 1 (Apaf-1) as a key committing steps
38.

The essentiality of Cytc for apoptosis is further strengthened by the fact that Cytc null

cell lines show reduced caspase-3 activation after stimulation of apoptosis 15, along with
a decreased rate of ATP production. Previous work also indicates that Cytc can be
reversibly released and taken up by isolated mitochondria

39,

and membrane rupture or

mitochondrial permeability transition pore opening are not always necessary for the
execution of apoptosis

40.

However, before the point of no return is reached, a certain

proportion of Cytc must be released from the mitochondria

41.

1.6.5 Cytochrome c-catalyzed cardiolipin oxidation precedes cytochrome c release
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Cardiolipin is a mitochondria-specific lipid and mainly localized in the inner
mitochondrial membrane where it binds ~15-20% of Cytc
functions as a cardiolipin peroxidase
for cardiolipin

44,45,

44,

42,43.

During apoptosis, Cytc

and this oxidation decreases the affinity of Cytc

thereby increasing the amount of free Cytc in the intermembrane

space, which can then be released into the cytosol once the mitochondrial outer
membrane is ruptured. This peroxidase function of Cytc depends on the physical
interaction between Cytc and cardiolipin and involves a tyrosine radical

44,46,47.

1.7 Cytochrome c regulation:
Being at the crux of the ETC, the terminal rate-limiting step of the ETC is
regulated by various means, as described hereunder.
1.7.1 Allosteric regulation
Both Cytc and COX are regulated allosterically by the ATP/ADP ratio. ATP
binds to Cytc and to COX, acting as an allosteric inhibitor

48-50.

The structure and

electrostatic properties of both the proteins are presumed to be changed upon ATP
binding, which decreases the capability of Cytc to transfer electrons

51,52,

thereby

downregulating ETC flux when there is already a high level of ATP within the cell.
1.7.2 Regulation via expression of tissue-specific isoforms
Another mode of regulation commonly seen in the ETC proteins is via tissuespecific isoform expression. A testis-specific isoform of Cytc (T-Cytc) exists in germinal
epithelial cells of rodents

53,

having 86% homology with the amino acid sequence of

somatic Cytc (S-Cytc), and is the predominant form of Cytc in mature sperm 53-55. T-Cytc
shows three-fold higher H2O2 reduction rates and about four-fold higher apoptotic activity
55.

However, this isoform is not evolutionarily conserved, and exists as a pseudogene in
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humans 7,56. Human Cytc, which is ubiquitously expressed including in testis, shows 91%
homology to mouse Cytc-S and 82% homology to Cytc-T.
1.7.3 Regulation by post-translational modifications
The third mode of Cytc regulation is by post-translational modifications. The
overall working hypothesis in our lab is that in higher organisms, the main mode regulating
energy production is through cell signaling pathways triggered by various extracellular
cues. Cytc has been found to be trimethylated at evolutionarily conserved residue Lys77
in S. cerevisiae and plants

57-60.

Also established is the role of Lys72-methylation in

determining the pro-apoptotic activity of Cytc

61.

Lys77-trimethylation was suggested to

be important for protection of Cytc from proteolytic cleavage, and abrogation of
proapoptotic activity. In addition, Cytc nitrosylation on its heme iron during apoptosis has
been suggested to increase the protein’s proapoptotic function

62.

1.7.3.1 Regulation by reversible phosphorylations
Over 400 phosphorylation sites have been mapped on the oxidative
phosphorylation complexes from various species to date

63,

and a few recent studies

indicate that several kinases and phosphatases are present in the mitochondria or that
they can translocate into the mitochondria after stimulation of signaling pathways as was
shown for the EGF receptor

64.

However, of the sites mapped, only a handful have been

functionally studied (mainly by our group), while the kinases and phosphatase involved in
these phosphorylations remain elusive for essentially all mapped sites. In mammals, 18
phosphorylation sites have been mapped on COX and 4 on Cytc 65,66.
The recent discovery of in vivo tyrosine phosphorylation of mammalian Cytc by
our lab has helped in our understanding of how kinases and phosphatases differentially
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modify Cytc functions during different cellular conditions. Cytc was previously isolated by
our lab in the presence of the nonspecific phosphatase inhibitors fluoride and vanadate
to maintain phosphorylations, and has been found to be phosphorylated on two different
highly conserved tyrosine residues by mass spectrometry, namely Tyr97 and Tyr48 in
heart and liver tissues, respectively 1,67. This indicates that cell signaling pathways target
the protein in a tissue-specific manner. As discussed above, oxidized Cytc exhibits a
specific absorption band at 695 nm due to a bond between a Met80 residue and the heme
iron, a signal called the “indicator of trouble”, which is lost when the protein is either
denatured or dysfunctional (Dickerson and Timkovich, 1975). Tyr97-phosphorylated Cytc
showed a shift in this band from 695 nm to 687 nm, suggesting an effect on the heme
environment 1. Both phosphorylations also had a direct effect on the various functions of
Cytc. For example, both tyrosine phosphorylations resulted in decreased, partially
inhibited oxygen consumption in the reaction with isolated COX in vitro, with Tyr97phosphorylated Cytc showing sigmoidal kinetics, while Tyr48-phosphorylated Cytc
showed hyperbolic kinetics, similar to alkaline phosphatase-treated unphosphorylated
Cytc

1,67.

Tyr48 phosphorylation has been studied in detail by creating a Tyr48Glu

phospho-mimetic mutant, and was shown to completely abolish activation of caspase3 in
vitro

68.

This suggests that Tyr48-phosphorylation might be an important regulator of the

protein’s function as an initiator of mitochondrial type II apoptosis. In the cellular context,
this regulation might be occurring through a phosphorylation-mediated change in
conformation of the native protein that changes the interaction between Cytc and Apaf1
in the cytosol, and results in impaired apoptosome formation. Lys7 is one residue that is
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important for this interaction

69,

and being spatially located right next to Tyr97, might be

regulated by phosphorylation of that site.
In addition to Cytc, COX subunits have also been found to be phosphorylated
at various sites by different pathways, including protein kinase C signaling, receptor
tyrosine kinase, and inflammatory signaling through the TNFα signaling pathway. It was
seen that after in vitro dephosphorylation of cow liver COX, the inhibitory effect of ATP on
COX was lost 70. This finding rationalizes studies of allosteric regulation of phosphorylated
Cytc and COX by ATP.
1.7.3.2 Regulation of Cytc by site-specific phosphorylations, in mammalian kidneys
and brain under physiologically healthy and stressed conditions
To continue my research on extending our knowledge and understanding of
how phosphorylation of Cytc affect its functions under healthy and stressed conditions, I
chose to work with tissues that are physiologically different than heart and liver tissues.
In Chapter 2, I show that mammalian kidney Cytc is phosphorylated at Thr28 under
physiologically healthy conditions, a conserved site in mammalian Cytc. My results
suggest that Thr28 is an important regulatory site, involved mainly in maintaining optimal
intermediate mitochondrial membrne potential (m) levels, thereby regulating energy
production and preventing ROS generation. Also, my results suggest that Thr28
phosphorylation of kidney Cytc in the mitochondrial intermembrane space is mediated by
AMPK, a metabolic sensor that was found to be basally active in kidney. In Chapter 3, we
show that neuroprotective insulin treatment prior to brain ischemia/reperfusion results in
phosphorylation of brain Cytc on Tyr97,

leading to decreased Cytc release from

mitochondria into the cytosol, resulting in reduced death of neurons, and thus
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neuroprotection. The data in Chapter 3 have been published
conclusions and future directions.

71.

Chapter 4, contains
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CHAPTER 2 AMPK-MEDIATED PHOSPHORYLATION OF CYTOCHROME c
THREONINE 28 REGULATES ELECTRON TRANSPORT CHAIN ACTIVITY IN
KIDNEY
2.1 Introduction
Cytochrome c (Cytc) is a small (12 kD) globular nuclear-encoded mitochondrial
protein containing a covalently attached heme group. It functions in the electron transport
chain (ETC) as a single electron carrier between bc1 complex (complex III) and
cytochrome c oxidase (CcO, complex IV), and is thus essential for aerobic energy
production. The second important role of Cytc is seen under conditions of stress, when it
functions as a crucial pro-apoptotic signal

72.

During apoptosis, Cytc is released from

mitochondria into the cytosol, where it interacts with Apaf-1 to form the apoptosome,
which in turn activates caspase-9 and the downstream executioner caspase cascade.
Furthermore, Cytc functions as a cardiolipin peroxidase during the early phase of
apoptosis, when it oxidizes the mitochondrial membrane lipid cardiolipin, thus facilitating
its own release from the inner mitochondrial membrane. In contrast, under healthy, nonapoptotic conditions Cytc acts as a scavenger of reactive oxygen species (ROS)

31,

and

it takes part in other redox reactions inside mitochondria including redox-coupled protein
import
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and reduction of p66Shc, a protein that is implicated in the generation of ROS,

apoptosis, and in regulating lifespan

34.

Given the multiple functions of Cytc it is not

surprising that it is tightly regulated. Two regulatory mechanisms via expression of a
somatic and testis-specific isoform pair and allosteric regulation through binding of ATP
have been known for over 30 years

49,53.

A third mechanism via reversible

phosphorylation was discovered recently when we purified bovine Cytc from heart and
liver tissue under conditions preserving the physiological phosphorylation status. The two
proteins were phosphorylated respectively on Tyr97 and Tyr48

73,74.

Both modifications
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lead to a partial inhibition of respiration. In addition, the phosphomimetic Tyr48Glu
substitution abolished the capability of Cytc to trigger apoptosis, suggesting that Cytc
phosphorylation regulates apoptosis at the level of the apoptosome

75.

Here we report

that Cytc purified from bovine and rat kidney tissues in the presence of phosphatase
inhibitors is phosphorylated on threonine 28 (Thr28). In vivo phosphorylated and
Thr28Glu phosphomimetic Cytc lead to an inhibition of respiration in the reaction with
CcO. Introduction of wild-type (WT) and Thr28Glu phosphomimetic Cytc into Cytc
knockout cells shows that intact cell respiration, mitochondrial membrane potential (m),
and ROS levels are reduced. This suggests that Cytc phosphorylation can regulate ETC
flux, preventing m hyperpolarization, a known trigger of ROS production and apoptosis
76.

Finally, we provide in vivo and in vitro evidence suggesting that phosphorylation of

Thr28 is mediated by AMP kinase (AMPK), which co-localizes with Cytc in the
mitochondrial intermembrane space. This is the first report of a mapped phosphorylation
site on a mammalian oxidative phosphorylation component, together with functional and
structural analyses and a kinase candidate mediating this site-specific modification.
2.2 Materials and methods
2.2.1 Isolation of cytochrome c from bovine kidney tissue
Reagents and chemicals were purchased from Sigma unless stated otherwise.
All procedures involving animal tissues were approved by the Wayne State University
Institutional Animal Care and Use Committee. Kidneys from freshly slaughtered cows
were snap frozen on dry ice, and stored at -80ºC until used for Cytc purification by the
acid-extraction method 74. For a detailed protocol see Supplemental Information.
2.2.2 Western analyses
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Western analyses were performed using the enhanced chemiluminescence
method. See Supplemental Information for antibody details.
2.2.3 Mass spectrometry of purified cytochrome c to detect site-specific
phosphorylation
Phosphorylation sites mapping on purified kidney Cytc was performed after
tryptic digestion and TiO2 enrichment of phospho-peptides, following C18 reversed-phase
chromatography as described 71. Peptides were injected into the mass spectrometer (LTQ
Orbitrap-Velos, Thermo Scientific, Waltham, MA) after electrospray ionization. MS/MS
spectra were obtained in positive ion mode, assigned to peptide sequences from the
UniProt protein database, searched with the MASCOT algorithm for PTMs, and manually
verified.
2.2.4 Mutagenesis, expression, and purification of cytochrome c variants
Rodent somatic Cytc cDNA was cloned into the pLW01 expression vector as
described 75 and threonine 28 (Thr28) was mutated to the phosphomimetic glutamate and
nonphosphorylatable alanine as an additional control by mutagenesis PCR. Constructs
were transformed into competent E. coli C41 (DE3) cells for protein overexpression

75.

Cells were lysed using a French Pressure Cell Press and Cytc variants were purified by
ion exchange chromatography as described above for kidney Cytc isolation. A similar
mutagenesis was used for expression of Cytc variants in Cytc double knockout mouse
lung fibroblasts using the pBABE-puro expression plasmid (Addgene, Cambridge, MA)
following selection of stably expressing cell lines. Wild-type and Cytc double knockout
lung fibroblasts were previously characterized in detail 77. See Supplemental Information
for details.
2.2.5 Crystal structure determination
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Briefly, using the PHENIX suite of programs

78,

the structure of WT Cytc was

solved by molecular replacement using chain-A of human Y46F Cytc 79, refit automatically
to the experimental electron density with PHENIX, and refined to obtain occupancy values
for the FC6 ligands. The refinement was completed to an R-free of 0.159 at 1.12 Å
resolution using REFMAC5

80

with parameters optimized by PDB_REDO

81.

The WT

structure (5C0Z.pdb) was then used to solve, refit, and refine the structures of the
Thr28Ala (5C9M.pdb) and Thr28Glu (5DF5.pdb) mutants at 1.36 Å (Rfree: 0.170) and
1.30 Å (Rfree: 0.178) resolution, respectively. All proteins were oxidized with 5 mM
K3Fe(CN)6 prior to crystallization. Full details and comparative statistics are provided in
Supplemental Table 1.
2.2.6 Cytochrome c oxidase (CcO) activity measurements
CcO activity with Cytc variants was determined using the polarographic method
as described 82. For a detailed protocol, see Supplemental Information.
2.2.7 Caspase 3 activation by cytochrome c variants
The capability of Cytc purified from bovine kidneys and the bacterially
expressed Cytc mutants to induce downstream caspase 3 activity were assessed in vitro
with cytoplasmic extracts of a mouse lung fibroblast cell line lacking both the somatic and
testis-specific Cytc genes

77

as described

75.

For a detailed protocol see Supplemental

Information.
2.2.8 Measurement of Cytc redox potential, heme degradation, and oxidation and
reduction rates
The midpoint redox potential (E0’) was analyzed spectrophotometrically as
described 75. The kinetics of oxidation of 15 µM ferro-Cytc with 100 µM H2O2 and reduction

18

of 15 µM ferri-Cytc with 200 µM ascorbate was measured spectrophotometrically at 550
nm, and heme degradation in the presence of 3 mM H2O2 was determined via dissipation
of the 408 nm Soret band as described

55.

For detailed protocols see Supplemental

Information.
2.2.9 Peroxidase activity of Cytc mutants
Assessment of peroxidase activity

75

with Amplex Red reagent was performed

by measuring the fluorescence of resorufin, an oxidation product of Amplex Red. Cytc (1
μM) was incubated with liposomes containing TOCL/DOPC in ratio 1:1 for 10 min.
Peroxidase reaction was started by addition of Amplex Red (50 μM) and H2O2 (50 μM)
and was carried out for 20 min during which the reaction rate was linear. Fluorescence
was detected by employing a “Fusion R” universal microplate analyzer by using an
excitation wavelength of 535 nm and an emission wavelength of 585 nm.
2.2.10 In vitro phosphorylation of cytochrome c with AMP kinase
Cow heart Cytc (300 pmoles; Sigma) was incubated with 3 pmoles of AMPK
(AMPK 1/1/1, Active SignalChem, P47-10H) at 37ºC for 5 or 30 min in the presence
and absence of AMP (125 M) in 25 mM MOPS (pH 7.2), 12.5 mM beta
glycerophosphate, 25 mM MgCl2, 2 mM EDTA, 0.25 mM DTT, and 1 mM ATP. Samples
were analyzed by Western blot and mass spectrometry.
2.2.11 Immunoprecipitation and Western analyses from tissue homogenates
All Western analyses from tissue homogenates were done using 20 µg of whole
tissue homogenates. All immunoprecipitations from tissue homogenates were done with
1 mg of tissue homogenate. For immunoprecipitations, 50 µL of bead (ImmunoCruz
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IP/WB Optima E and F Systems: sc-45042 and sc-45043) and 5 µg antibody were allowed
to conjugate overnight at 4ºC, centrifuged (22,000 x g) for 30 seconds and washed twice
with 500 µL PBS. Immunoprecipitation was performed by addition of 1 mg tissue
homogenate and rotation overnight at 4ºC.
2.2.12 Tissue Treatments with AMPK activator A-769662 and inhibitor Compound
C
Fresh mouse kidneys were minced and treated with 500 µM A769662 (AMPK
activator, Tocris, #3336) or 3 µM Compound C (AMPK inhibitor, Sigma, P5499) for 1 h
following Western analysis of the soluble fraction. In addition, AMPK was
immunoprecipitated from kidney homogenates after treatment with 500 µM A769662 for
1 h to analyze Cytc co-immunoprecipitation. See Supplemental Information for details.
2.2.13 Measurement of mitochondrial oxygen consumption rate tissue
homogenates
Respiration of intact mitochondria in tissue homogenates was determined as
described 83. For a detailed protocol see Supplemental Information.
2.2.14 Presence of AMP kinase in mitochondria and mitochondrial subfractionation
Mouse kidneys were freshly harvested and washed in ice-cold isolation buffer
(10 mM Tris, 1 mM of EGTA/Tris, 200 mM sucrose, pH 7.4 adjusted with MOPS)

84,

minced, and homogenized with 20 strokes using a dounce homogenizer on ice following
mitochondria isolation by sucrose density gradient purification. The mitochondrial pellet
was subfractionated into an intermembrane space fraction and a mitoplast and outer
membrane fraction. For detailed protocols see Supplemental Information.
2.2.15 Measurement of oxygen consumption rate in intact cells
Per well, 70,000 cells were cultured in growth media (DMEM, supplemented
with 10% FBS, 2% penicillin/streptomycin, 1 mM pyruvate and 50 µg/mL uridine) using
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Seahorse XFe24 plates. After overnight culture, growth media was replaced with XF
media, pH 7.4, and intact cell respiration was measured.
2.2.16 Mitochondrial ROS measurement
Cells expressing Cytc variants were cultured in 12 well plates and incubated
with 5 µM Mitosox for 30 min in at 37ºC. Cells were washed with PBS and fluorescence
analyzed with a Synergy H1 plate reader (BioTek, Winooski, VT) by using excitation and
emission wavelengths of 510 nm and 590 nm.
2.2.17 ATP, mitochondrial membrane potential, and cell viability measurements
ATP levels were measured from lung fibroblast cells expressing Cytc variants
applying the bioluminescent method. Mitochondrial membrane potential (ΔΨm) and cell
viability were measured with JC-1 (Molecular Probes) and tryphan blue staining,
respectively. For detailed protocols see Supplemental Information.
2.2.18 Isolation of cytochrome c from bovine kidney tissue
All steps were performed at 4ºC or on ice. Kidney tissues were homogenized
in 100 mM phosphate buffer, pH 4.5, adjusted with acetic acid, and incubated overnight
at 4ºC. Under those conditions most cellular proteins denature and precipitate, whereas
Cytc is extracted and stays in solution. The homogenate was centrifuged at 15,810 x g
for 35 min, supernatants decanted through cheesecloth, and pH adjusted to 7.4 with KOH,
while simultaneously adding protease (10 mM PMSF) and phosphatase inhibitors (1 mM
KF, 1 mM Na-orthovanadate), thus preserving the phosphorylation state of Cytc. The
supernatant was incubated at 4ºC for 20 min and centrifuged following ion exchange
chromatography. First, the supernatant was passed through a DE52 anion exchange
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column equilibrated with 20 mM phosphate buffer, pH 7.4, 3.6 mS/cm conductance. Cytc
was collected in the flow through, which was pH readjusted to 6.5 and applied to a CM52
cation exchange column equilibrated with 30 mM phosphate buffer, pH 6.5, 5.5 mS/cm
conductance. Cytc bound to the CM52 column was oxidized on the column with 2 mM
K3Fe(CN)6, and was eluted by step gradient using 30, 50, 80, 120, and 150 mM
phosphate buffers, pH 6.5. To obtain a highly pure fraction of Cytc, the DE52 and CM52
ion exchange chromatography steps were repeated. For further purification HPLC sizeexclusion chromatography, with a column equilibrated with 150 mM phosphate buffer, pH
6.5, was performed and a mixture of phosphorylated and nonphosphorylated Cytc was
obtained. The protein was concentrated under vacuum, desalted by centrifugation using
Amicon Ultra-15 3kDa centrifugal filter units (Millipore, Billerca, MA), and stored at -80ºC.
2.2.19 Protein concentration and purity determination
Purified Cytc was reduced with 100 mM sodium dithionite, desalted with NAP5 columns (GE Healthcare, Piscataway, NJ), and analyzed on a Jasco V-570 double
beam spectrophotometer (2 nm band width). The concentration was determined by
differential spectra at 550 nm by subtracting the oxidized form from the reduced and
calculated via ɛ(red.–ox.)550 nm=19.6 mM−1 cm.−1 Purity of the protein was confirmed by
Coomassie staining after 12% Tris-Tricine SDS PAGE.
2.2.20 Gel electrophoresis and Western blotting
Western analyses were performed to analyze the phosphorylation status of
purified Cytc, with a 1:5000 dilution of primary antibodies: anti-phospho tyrosine (4G10,
Millipore, Bilerica, MA), anti-phosphoserine (set of four individual monoclonal antibodies,
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1C8, 4A3, 4A9, and 16B4, EMD Biosciences, Gibbstown, NJ), and anti-phosphothreonine
antibodies (set of three individual monoclonal antibodies, 1E11, 4D11, and 14B3, EMD
Biosciences, Gibbstown, NJ) followed by a 1:10,000 dilution of anti-mouse IgG or IgM
horseradish peroxidase conjugated secondary antibody (GE Healthcare). EGFstimulated A431 total cell lysate (Upstate, Bilerica, MA) was used as a positive control
and ovalbumin as a negative control. Signal detection was performed with an enhanced
chemiluminescence method (GE Healthcare, Piscataway, NJ). The following antibodies
were used at a dilution of 1:1,000: complex I NDUFB6 (MS108, MitoSciences, Eugene,
OR); complex II 70kD subunit (MS204, MitoSciences, Eugene, OR); complex III core I
(MS303, MitoSciences, Eugene, OR); complex IV Subunit I (MS404; MitoSciences,
Eugene, OR); complex IV subunit IV (sc58348, Santa Cruz Biotechnology, Dallas, TX);
cytochrome c (556433, BD Pharmingen, San Jose, CA); porin (MSA03, MitoSciences,
Eugene, OR); and GAPDH: (ab9484, Abcam). To separate Thr28-phosphorylated from
unphosphoryated Cytc a 15% acrylamide/2.6% bisacrylamide gel (Tris-tricine-SDS
PAGE) was prepared. Cytc (500 ng) was denatured in 2x sample buffer (NuPAGE,
NP0007, Invitrogen) with 100 mM DTT and 3% mercaptoehanol. Anode and cathode
buffers were 0.2 M Tris pH, 8.9 and 100 mM Tris, 100 mM Tricine, 0.1% SDS, pH 8.25)
and gels were run at a low voltage (80 V) for up to 4 h.
2.2.21 Mutagenesis, expression, and purification of cytochrome c variants
Mouse somatic Cytc cDNA was cloned into the pLW01 expression vector (kind
gift from Dr. Lucy Waskell, University of Michigan) that also contained the cDNA encoding
heme lyase (CYC3), an enzyme necessary for the covalent attachment of the heme group
to apo-Cytc. Threonine 28 (Thr28) in the wild type Cytc cDNA was mutated to the
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phosphomimetic glutamate and nonphosphorylatable alanine as an additional control.
Forward

primers

5'-AAGCATAAGGAGGGACCAAA-3'

AAGCATAAGGCTGGACCAAA-3'
complement

primers

(Tm=53.8C)

and

(Tm=53.8C)

corresponding

5'-TTTGGTCCCTCCTTATGCTT-3'

and

5'-

reverse

and

(Tm=54.6C)

and

5'-

TTTGGTCCAGCCTTATGCTT-3' (Tm=54.6C) were used for Thr28Glu and Thr28Ala
mutagenesis PCR, respectively. The outer primers that amplified the entire Cytc cDNA
sequence

containing

NcoI

and

BamHI

AATTTACCATGGGTGATGTTGAAAAAG-3'

restriction

sites

(Tm=56.7C)

were
and

5'5'-

AATAAAGGATCCAGTGGAATTATTCAT-3' (Tm=54.7C), respectively. The mutated
Cytc cDNA sequences were subcloned into the pLW01 bacterial expression plasmid after
restriction digestion with NcoI and BamHI. Note that the Cytc cDNA contains an internal
NcoI restriction site; thus the fragments were first fully digested with BamHI following
partial (3 min) digestion with NcoI and purification of the correct size fragment after
agarose gel electrophoresis. Constructs were confirmed by sequencing and used to
transform competent E. coli C41 (DE3) cells for protein overexpression

75.

The clones

were inoculated into 20 mL TB medium (Difco, BD, Franklin Lakes, NJ) containing 100
μg/mL carbenicillin and grown overnight at 37ºC under shaking. These cultures were used
to inoculate 4 L of 100 μg/mL carbenicillin-containing TB medium and were grown until
an OD600 of 2-3 was reached. At this time, the expression of cytochrome c was induced
by addition of 100 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), and the protein was
overexpressed for 6 h at 37ºC. The cells were harvested by centrifugation for 40 min at
8,400 x g, 4ºC, and the pellets were immediately stored at -80ºC until used for Cytc
extraction. The bacterial pellets were resuspended in lysis buffer containing 20 mM
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phosphate buffer, pH 7.4 supplemented with a protease inhibitor cocktail (P8340, Sigma)
as recommended by the manufacturer. For every 10 g of bacterial pellet 100 ml of lysis
buffer were used and the resuspended cells were lysed using a French Pressure Cell
Press (American Company, Aminco). The lysates were centrifuged at 15,000 rpm for 45
min, the pH of the supernatant was adjusted to 7.4 and Cytc variants were purified by ion
exchange chromatography as described above for kidney Cytc isolation. For expression
of Cytc variants in Cytc double knockout mouse lung fibroblasts the pBABE-puro
expression plasmid (Addgene, Cambridge, MA) was used. A similar PCR mutagenesis
approach was performed as above and fragments were cloned into the BamHI and EcoRI
restriction sites using the primers outer forward primer pBABE

5’-

ATCTTGTGGAAAGGACGCGGGATCCATGGGTGATGTTGAAAAA-3’ (Tm=68.0C) and
outer reverse primer pBABE 5'GGTCGACCACTGTGCTGGCGAATTCTTACTTATCGTCGTCATCCTTGTAATCTTCAT
TAGTAGCC-3' (Tm=68.8C). The resultant C-terminal 1XFLAG-tagged wild-type,
Thr28Glu phosphomimetic mutant, and Thr28Ala non-phosphorylatable mutant
constructs were transfected into Cytc double knockout lung fibroblast cells and cultured
in DMEM media (high glucose, Gibco BRL), supplemented with 10% fetal bovine serum,
1000 units penicillin/streptomycin, 1mM pyruvate, 50 g/mL uridine at 37°C and 5% CO2.
Stable cell lines expressing the three Cytc variants as well as an empty vector control cell
line were selected in the presence of 4 µg/mL puromycin.
2.2.22 Circular dichroism spectroscopy
Circular dichroism (CD) spectra of cytochrome c variants (wild type, Thr28Ala,
Thr28Glu, and bovine heart cytochrome c (Sigma)) were recorded on a Jasco J-815
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spectrometer using a 0.6 mm path length quartz cuvette. Proteins were diluted to 220 μM
final concentration in 100 mM phosphate buffer, pH 7.4, and 1 mL protein solution was
reduced with 250 μM ascorbate. An average of 3 scans were collected at 20°C at a
resolution of 1 nm.
2.2.23 Crystallization of WT, T28A, and T28E cytochrome c, and data analysis
Cytc was gel-filtered on a S100 column to reduce aggregates and concentrated
to 15 mg/mL or higher in water. To establish a defined oxidation state, the proteins were
oxidized with 5 mM K3Fe(CN)6 prior to crystallization. Crystals were grown by vapor
diffusion after mixing 1 L of protein solution with 1L of precipitant solution and
equilibrating the drop against 0.5 mL of the precipitant at room temperature. The
respective precipitant solutions for crystals of the WT, T28A, and T28E Cytc are listed in
Supplemental Table 1. Crystals usually appeared within 1 week. Crystals were soaked
for 10 minutes in a cryo-protectant solution (Supplemental Table 1) before flash freezing
in liquid nitrogen. Single crystal diffraction data were collected at the Life Sciences
Collaborative Access Team facility (Advanced Photon Source sector 21, Argonne
National Laboratory). The data were collected over a full 360° rotation in either 0.6 or 1.0
degree frames and integrated using XDS
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in AutoProc

86.

For structure solution and

refinement the native data set was solved using chain-A of the human Y48F Cytc structure
(3ZOO.pdb) in PHENIX 78. It was refit with AutoBuild in the PHENIX suite and refined with
PHENIX initially to get occupancies for the FC6 molecules. The refinement was
completed with Refmac5 in CCP4 using refinement parameters and weights optimized
with PDB_REDO. In particular, PDB_REDO recommended anisotropic temperature
factors based on the Hamilton ratio test for all three structures. Electron density was
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analyzed with COOT

87

in the CCP4 suite of crystallographic programs

88.

The FC6

ligands were located and placed in an anomalous diffraction difference map with COOT.
Using the WT structure as an example, the highest 8 peaks - in order - in the map, are
the 4 heme iron atoms, followed by FC6 202/C, FC6 202/B, FC6 202b/A, and FC6 203b/B.
The next 3 peaks are for three sulfur atoms (Cys14/A, Cys17/B, Met80/D) followed by
FC6 202a/A and FC6 202a/B. The last two FC6 positions were included because they
had sufficient 2Fo-Fc density to fit several of their cyanide groups.
2.2.24 Molecular dynamics and ESP calculations
Molecular dynamics were performed with YASARA

89

using its conservative

“slow” protocol and the recommended default force field, AMBER 2003 90. The Root Mean
Square Fluctuations (RMSF) and average structures plotted in Figure 3 were calculated
with default scripts in the YASARA library. Electrostatic potentials (ESP) in vacuo were
calculated with YASARA to highlight the charge distribution using the recommended
NOVA force field 91 and the Particle Mesh Ewald algorithm 92. The rectangular simulation
cell for the ESP calculations was 15Å from all atoms in the tetramer. No ligands were
included in the calculation. Molecular images including the superpositions were calculated
in YASARA 89. Plots were generated with Excel using data imported from YASARA. The
three electron density plots in Figure 3 were assembled with PyMOL (The PyMOL
Molecular Graphics System, Version 1.8 (2015) Schrödinger, LLC) using electron density
calculated by COOT. The final assembly of all figures was done in Photoshop.
2.2.25 Cytochrome c oxidase (CcO) activity measurements
Briefly, an aliquot of regulatory competent bovine liver CcO, which has the
same isozyme complement as kidney CcO, was diluted to 3 μM final concentration in the
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presence of a 40-fold molar excess of cardiolipin and 0.2 mM ATP in CcO measuring
buffer (10 mM K-HEPES (pH 7.4), 40 mM KCl, 1% Tween 20) and dialyzed overnight at
4ºC to remove cholate bound to CcO during enzyme purification. Respiration of CcO (150
nM) was analyzed in a closed chamber equipped with a micro Clark-type oxygen
electrode (Oxygraph system; Hansatech, Pentney, UK) at 25ºC in 220 μL of CcO
measuring buffer and 20 mM ascorbate as electron donor. Increasing amounts of purified
Cytc variants (0-25 μM) were added, and oxygen consumption was recorded and
analyzed with the Oxygraph software (Hansatech). CcO activity was expressed as
turnover number (TN; sec-1).
2.2.26 Caspase 3 activation by Cytc variants
Cells from eight 150 mm plates were collected by centrifugation at 4ºC. The
pellet was washed once in 5 mL of ice cold cytosol extraction buffer (20 mM HEPES, pH
7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM
PMSF), resuspended gently in the same buffer, and immediately transferred to an ice
cold dounce homogenizer. After 15 min of swelling on ice cells were then broken open
with a B-type glass pestle, and cell breakage confirmed using a microscope. The lysates
were transferred to microcentrifuge tubes and centrifuged at 4ºC and 15,000 x g for 15
min to remove nuclei and other debris. The protein concentration of the cytosolic fractioncontaining supernatant was measured using the DC Assay kit (Bio Rad, Hercules, CA)
and cytosolic extracts were diluted to 2 mg/mL. EnzChek Caspase-3 assay kit (Invitrogen,
Carlsbad, CA) with rhodamine 110-linked DEVD tetrapeptide, an artificial substrate for
caspase 3 that fluoresces upon cleavage, was used. Cytosolic extracts from Cytc double
knockout lung fibroblast cells (2 mg/mL concentration) were incubated with the Cytc
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variants (15 µg/mL) for 2.5 h at 37ºC. Caspase 3 activity was assessed in the presence
or absence of the caspase 3 inhibitor by detection of fluorescence from the cleavage of
the artificial caspase 3 substrate over 3 h in 30 min intervals using a Fluoroskan Ascent
FL plate reader (Labsystems, Thermo Scientific, Waltham, MA), 485 nm excitation filter
(14 nm band width) and 527 nm emission filter (10 nm band width). Amount of cleaved
substrate was calculated from the rhodamine 110 calibration curve, and data were
expressed in pmol of DEVD3 min-1 (mg protein)-1.
2.2.27 Measurement of Cytc redox potential
The midpoint redox potential (E0’) was analyzed spectrophotometrically as
described 75 using 2, 6 dichloroindophenol (DCIP, E0’=237 mV) as a reference compound,
which has an absorption band at 600 nm in its oxidized state. One mL of Cytc solution (2
mg/mL) was mixed in a spectrophotometric cuvette with 2 mL of 50mM citrate buffer, pH
6.5, 0.1 mL of 1 mM DCIP, and 50μL of 1 mM K 3Fe(CN)6 to fully oxidize Cytc.
Absorbances corresponding to fully oxidized Cytc (A550-A570) and DCIP (A600) were
recorded using a Jasco V-570 double beam spectrophotometer. The mixture was then
sequentially reduced by 1 μL additions of 5 mM ascorbate (pH 6.5), and absorbance
values were acquired at each step. When readings became constant, a few grains of
sodium dithionite (Na2S2O4) were added to fully reduce Cytc and DCIP. For each step,
ratios of oxidized and reduced forms of both compounds were calculated. Data obtained
were plotted as log(DCIPOX/DCIPRED) versus log(CytOX/CytRED), yielding a linear graph
with a slope of n-DCIP/n-Cytc and a y-axis intercept of n-Cytc / 59.2(E Cytc – E DCIP).
These values were used to calculate the E0’ (mV) of Cytc from the Nernst equation.
2.2.28 Measurement of rates of oxidation and reduction
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The kinetics of oxidation of 15 µM ferro-Cytc with 100 µM H2O2 and reduction
of 15 µM ferri-Cytc with 200 µM ascorbate was measured spectrophotometrically at 550
nm as described

55.

Briefly, WT Cytc and T28E and T28A Cytc mutants were reduced

with sodium dithionite, and the proteins separated from the reductant through NAP5
columns. Fifteen µM Cytc in 0.2 M Tris-Cl, pH 7.0 were incubated with 100 µM oxidizing
agent H2O2 and after 10 sec, the decrease of the absorption peak at 550 nm was
measured, and the amount of oxidized Cytc was calculated as described above. To
measure the kinetics of reduction of Cytc with ascorbate, Cytc variants were fully oxidized
with K3Fe(CN)6 and purified using NAP5 columns. Fifteen µM ferri-Cytc was added to 50
mM sodium phosphate, 25 mM sodium dithionite (Na2SO4), pH 7.0 and 200 µM ascorbate
to a cuvette, which was then sealed from air, and the initial rate of reduction was
measured at 550 nm.
2.2.29 Heme degradation assay
The degradation of heme was analyzed through dissipation of the Soret band
at 408 nm using 5 µM ferri-Cytc from in 50 mM phosphate buffer, pH 6.1 with 3 mM H2O2
as described

55.

Spectra were scanned initially after 60 seconds followed by

measurements every 200 seconds.
2.2.30 Measurement
homogenates

of

mitochondrial

oxygen

consumption

rate

tissue

Respiration of intact mitochondria in tissue homogenates was determined as
described

83,

using freshly harvested kidney tissues following treatment with AMPK

activator and inhibitor as above, following homogenization in homogenization buffer with
ten strokes. The protein concentration was determined using the DC protein assay kit
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(Bio-Rad)., and diluted to 0.2 mg/mL with KCl buffer (80 mM KCl, 10 mM Tris–HCl, 3 mM
MgCl, 1 mM EDTA, 5 mM potassium phosphate, 2.5 mM malate, 0.5 mg/ml BSA, pH 7.4).
Mitochondrial respiration was measured at 30ºC using a Clark-type oxygen electrode as
described above.
2.2.31 Tissue Treatments with AMPK activator A-769662 and inhibitor Compound
C
Wild-type male mice, 2-4 months old littermates, were housed at 23°C under
12hr:12hr light:dark periods. Animals were euthanized following NIH guidelines and
immediately after the animals died their kidneys taken out and placed in ice cold ST buffer
containing 250 mM sucrose, 20 mM Tris, pH 7.4, 10 mM KF, 1 mM PMSF, 1 mM sodium
orthovanadate, supplemented with protease inhibitor cocktail (Sigma) and phosphatase
inhibitor cocktails 2 (P5726, Sigma) and 3 (P0044, Sigma) according to manufacturer’s
protocol. Kidneys were then minced with scissors on an ice cold glass plate and equal
weight (80 mg) placed in tubes containing 2 ml buffer following treatment with either 500
µM A769662 (AMPK activator, Tocris, #3336), 3 µM Compound C (AMPK inhibitor,
Sigma, P5499), or DMSO (no treatment control) for 1 h at 37ºC under shaking. Tubes
were put on ice, tissues pelleted by centrifugation, and buffer replaced with 1 mL
homogenization buffer (50 mM Tris-Cl, pH 7.5, 1 mM EGTA, 1% Triton-X 100, 1 mM
sodium orthovanadate, 50 mM KF, 5 mM sodium pyrophosphate, 0.27 M sucrose, 0.1%
-mercaptoethanol, supplemented with protease inhibitors and phosphatase inhibitor
cocktails as above, and homogenized using a Teflon dounce homogenizer by applying
60 strokes. Homogenates were centrifuged at 22,000 x g at 4ºC for 30 min and
supernatants' total protein levels were quantitated using the DC protein assay kit (BioRad).. Twenty g tissue homogenates were loaded for immunoblot analyses to check for
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total and phospho AMPK levels and phospho-acetyl CoA carboxylase (p-ACC) levels
(AMPKα1/2 antibody (H-300), sc-25792; p-AMPKα1/2 antibody (Thr 172), sc-33524,
Santa Cruz Biotechnology, Dallas, Texas, USA; p-Acetyl-CoA Carboxylase (Ser79)
antibody #3661, Cell Signaling Technology, Danvers, MA, USA; antibody dilution
1:1000). Subsequently, 1 mg homogenate was used for overnight immunoprecipitation of
Cytc. A 10% Tris-tricine-SDS PAGE was run to analyze total and phospho AMPK levels,
phospho-ACC levels, and threonine phosphorylation of immunoprecipitated Cytc (using
a 1:250 dilution of a set of three individual monoclonal anti-phosphothreonine antibodies,
1E11, 4D11, and 14B3, EMD Biosciences, Gibbstown, NJ). In addition, AMPK was
immunoprecipitated from kidney homogenates after treatment with 500 µM A769662 for
1 h to analyze Cytc co-immunoprecipitation.
2.2.32 Sucrose-density gradient isolation of mitochondria and subfractionation
Lung fibroblasts were harvested and resuspended in 10 mM NaCl, 1.5 mM
MgCl2, 10 mM Tris-Cl, pH 7.5. They were allowed to swell for 5 min on ice, and
homogenized using a Teflon-glass homogenizer. The sucrose concentration was
adjusted to 250 mM by adding 2 M sucrose and TE buffer (10 mM Tris-Cl, 20 mM EDTA,
pH 7.6). The homogenate was centrifuged twice at 1,300 x g for 3 min, the supernatant
collected and centrifuged at 15,000 x g for 10 min, and washed three times with 250 mM
sucrose/TE buffer. The mitochondrial fraction was layered on a discontinuous sucrose
gradient containing 1M sucrose and 1.7 M sucrose in TE buffer. Centrifugation was
performed at 70,000 x g for 40 min at 4ºC and mitochondria retrieved from the interface.
Mitochondria were washed in 250 mM sucrose/TE buffer and collected by centrifugation
at 22,000 x g for 15 min to obtain highly pure mitochondria. The mitochondrial pellet was
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resuspended in 20 mM sodium phosphate buffer, pH 7.2, 0.02% BSA, and allowed to
swell for 20 min on ice, then 1 mM ATP and 1 mM MgCl2 were added, followed by
incubation on ice for 5 min, and centrifugation at 15,000 x g for 10 min at 4ºC. The
supernatant contained the intermembrane space fraction and the pellet contained
mitoplasts, the outer membrane fraction, and residual intermembrane space fraction.
2.2.33 Isolation and subfractionation of mitochondria from mouse kidneys
Mouse kidneys were freshly harvested and washed in ice-cold isolation buffer
(10 mM Tris, 1 mM of EGTA/Tris, 200 mM sucrose, pH 7.4 adjusted with MOPS)

84.

Kidneys were minced with scissors on an ice-cold glass plate and homogenized with 20
strokes using a dounce homogenizer on ice. The homogenate was centrifuged at 600 x
g for 10 min and the supernatant centrifuged at 7,000 x g for 10 min to pellet mitochondria.
The mitochondrial pellet was subfractionated into an intermembrane space fraction and
a mitoplast and outer membrane fraction as described above.
2.2.34 ATP assay
Lung fibroblast cells expressing Cytc variants were scraped and collected and
immediately stored at -80ºC until measurement. Release of ATP was performed by boiling
method after addition of 300 μL of boiling buffer (100 mM Tris-Cl, pH 7.75, 4 mM EDTA),
and immediate transfer of the samples to a boiling water bath for 2 min. Samples were
put on ice, sonicated, diluted 300-fold, and 40 μL of the diluted samples were used to
determine the ATP concentration with the ATP biolumescence assay kit HS II (Roche,
Indianapolis, IN) according to the manufacturer's protocol. Data were standardized to the
protein concentration using the DC protein assay kit (Bio-Rad).
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2.2.35 Measurement of the mitochondrial membrane potential (ΔΨm)
Lung fibroblast cells expressing Cytc variants were grown to 80% confluence.
To assess relative changes in mitochondrial membrane potential (ΔΨm), cells were
incubated for 30 min in phenol red-free medium containing 1 μM JC-1 (Molecular Probes).
JC-1 is able to selectively enter mitochondria, is a monomer at low concentration or at
low membrane potential, and emits green fluorescence. At higher membrane potential
JC-1 forms aggregates that emit red fluorescence. Cells were washed with PBS and
fluorescence measured with an Ascent Fluoroskan plate reader by using an excitation
wavelength of 485 nm and an emission wavelength of 590 nm for red aggregates and
527 for green monomers.
2.2.36 Cell viability
Cells (100,000 per well in six-well plates) expressing Cytc variants were and
grown for 48 h, trypsinized, and live cells were counted after staining with trypan blue.
For cell viability analyses after treatment with H2O2, cell number was doubled and cells
were treated with 50 µM and 300 µM H2O2 for 24 h followed by trypan blue staining.
2.2.37 Statistical analyses
Statistical analyses were performed using MSTAT version 5.4 (N. Drinkwater,
University of Wisconsin) in conjunction with the Wilcoxon rank-sum test. Data (n=3-4) are
reported as means ±SD and were considered statistically significant (*) with p<0.05.
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2.3 Results
2.3.1 Mammalian kidney cytochrome c is phosphorylated on Thr28 leading to
‘controlled’ respiration.
To test if Cytc phosphorylation occurs in mammalian tissues other than heart
and liver, where it is tyrosine phosphorylated, we chose kidney, an organ with a high
mitochondrial capacity and the second highest oxygen consumption rate only after heart
93.

Surprisingly, Western analysis of Cytc from bovine kidney detected phosphorylation

on threonine (Figure 1A) but not on tyrosine (not shown). Mass spectrometry
unambiguously revealed that Thr28 was phosphorylated in three independent Cytc
isolations analyzed (Figure 1B). This amino acid is conserved in mammals, both in the
somatic and testes-specific isoform (Supplemental Figure 1A). To test the effect of Thr28
phosphorylation we measured the kinetics of Cytc with isolated CcO. Oxygen
consumption rate was 50% lower at maximal turnover for Thr28 phosphorylated versus
unphosphorylated Cytc (Figure 1C). Phosphorylation of Thr28 also dropped the apparent
KM of Cytc in the reaction with CcO from 6.3 to 4.5. Similar to Tyr48 and Tyr97
phosphorylation, Thr28 phosphorylation leads to partial inhibition of respiration, or
‘controlled respiration,’ which we propose prevents m hyperpolarization and thus ROS
production under non-stressed conditions. In order for a posttranslational modification
(PTM) to be biologically relevant a significant fraction of the protein should carry the
modification. Using high resolution gel electrophoresis which separates phosphorylated
and unphosphorylated Cytc we found that over 80% of the Cytc pool was phosphorylated
(Figure 1D).
2.3.2 Overexpression and purification of functional and correctly folded
cytochrome c variants in E. coli cells
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We and others have previously shown for tyrosine phosphorylated Cytc that
phosphomimetic replacement of the phosphorylatable residue with the negatively
charged glutamate produces functional effects similar to those seen with the in vivo
phosphorylated protein 75,94. This approach has the advantage that large amounts of the
phosphomimetic Cytc can be overexpressed in bacteria and purified, and that the
negative charge introduced through the glutamate residue is stable whereas attached
phosphates may be lost during assays that require prolonged incubation periods or
contain cytosolic extracts that contain phosphatases. We thus generated the following
Cytc variants based on the mouse sequence and overexpressed them in E. coli BL21
(DE3) cells: WT, phosphomimetic Thr28Glu, and Thr28Ala Cytc as additional control,
which cannot be phosphorylated. Cytc variants were purified using a French press
followed by anion and cation ion-exchange chromatography. Purity of Cytc was confirmed
by Coomassie staining (Figure 2A) and spectrophotometric analysis, with 410 nm/280 nm
ratios >4

75.

All three proteins were fully reducible and correctly folded as shown by

absorption spectra measurements (Supplemental Figure 1B) and circular dichroism
(Supplemental Figure 1C). Similar to our previous study

75,

none of the bacterially

overexpressed proteins were Ser-, Thr-, or Tyr-phosphorylated (not shown). The redox
midpoint potential of Cytc is approximately midway between the redox potentials of
complexes III and IV, and values reported in the literature range from 220 and 270 mV 95.
We analyzed the redox midpoint potential spectrophotometrically by the equilibration
method using 2,6-dichloroindophenol as the reference compound. The redox potentials
for WT, Thr28Ala, and Thr28Glu were 246 mV, 221 mV, and 217 mV (Figure 2B),
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suggesting that a modification on position 28 can lower the redox potential of Cytc, similar
as we have reported for phosphomimetic Tyr48Glu Cytc 75.

Figure 1. Kidney cytochrome c is phosphorylated on threonine 28 leading to
controlled respiration.
(A) Purification of cow kidney Cytc indicates threonine phosphorylation. Lane 1, kidney
Cytc; lane 2, cow heart Cytc (Sigma); lane 3, ovalbumin (Western negative control); lane
4, EGF treated cell extract (Western positive control). Top, Coommassie gel; bottom antiphospho-Thr Western blot.
(B) Nano-LC/ESI/MS/MS spectrum of HKpTGPNLHGLFGR reveals phosphorylation of
Thr28. The phosphorylation site was unambiguously assigned by fragment ions y10 and
y11. The sequence of the peptide was assigned by b2, b8, b9, y1, y2, y4, y5, y6, y8, y9,
and y10.
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(C) In vitro cytochrome c oxidase activity with in vivo phosphorylated pThr28 (pT28) is
50% reduced at maximal turnover compared to unphosphorylated Cytc.
(D) High resolution gel electrophoresis indicates that 83% of the Cytc pool is
phosphorylated (lane one, upper band). Lane 2, unspecific phosphatase treatment of Cytc
collapses the upper band.

2.3.3 Phosphomimetic cytochrome c displays a significantly decreased reaction
rate with isolated cytochrome c oxidase (CcO)
We showed that in vivo phosphorylated Cytc displayed an approximately 50%
inhibition in the reaction with isolated bovine liver CcO (Figure 1C). To demonstrate that
Thr28Glu is a good model for Thr28 phosphorylated Cytc we first analyzed its activity in
the reaction with purified CcO. As shown in Figure 2C, we found that respiration rates of
phosphomimetic Thr28Glu and Thr28Ala Cytc were 73% and 51% reduced, respectively,
indicating that Thr28Glu Cytc serves as a useful model. The apparent KM of Cytc in the
reaction with CcO was 7.8, 9.3, and 4.7 for unphosphorylated WT, Thr28Glu, and
Thr28Ala Cytc, respectively. The fact that the inhibitory effect of the phosphomimetic
substitution is even more pronounced than that observed with in vivo phosphorylated Cytc
may be due to the subfraction (about 20%) of unphosphorylated Cytc present when
isolated from kidneys.
2.3.4 Thr28Glu cytochrome c is capable to trigger caspase-3 activation but shows
distinct features in its ROS-related functions
To test the possible effect of Thr28 phosphorylation on apoptotic function, we
analyzed the ability of the Cytc variants to trigger apoptosis by measuring downstream
activation of caspase-3 using a cell-free caspase assay. Cytc mutants were incubated
with cytosolic fractions prepared from mouse lung fibroblasts in which both the somatic
and testes-specific isoforms of Cytc were knocked out 77. The Thr28Glu mutant was able
to activate caspase-3 similar to wild-type Cytc protein (Figure 2D) and Thr28phosphorylated Cytc (Supplemental Figure 2), indicating that Thr28 phosphorylation of
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Cytc does not affect the function of Cytc at the level of apoptosome formation. Other
functions of Cytc include ROS scavenging, such as reduction by superoxide to regenerate
oxygen or oxidation by H2O2. We therefore tested the ability of Cytc in the reaction with
H2O2 and with the reductant ascorbate. To analyze the former, ferro-(Fe2+)-Cytc variants
were oxidized in the presence of 100 µM H2O2. The Thr28Glu phosphomimetic mutant
was oxidized at a rate similar to WT Cytc, while Thr28Ala mutant was oxidized at a 2.7fold higher rate (Figure 2E). At higher ROS load Cytc can lose its functionality through
oxidative modifications, which can be monitored through a decrease in the absorption of
the heme Soret band at 408 nm present in intact Cytc. After addition of excess H2O2 (3
mM) Thr28Glu Cytc was more resistant to degradation by excess H2O2 than the wild-type,
while the Thr28Ala mutant was degraded more rapidly (Figure 2F), suggesting that the
introduction of a negative charge in position 28 stabilizes the protein. To determine the
rate of Cytc reduction, ferri-(Fe3+)-Cytc variants were reduced in the presence of 200 µM
ascorbate. Thr28Glu Cytc was reduced at about twice the rate compared to WT and
Thr28Ala Cytc (Figure 2G), suggesting that it can act as a superior electron acceptor and
scavenger.
Cardiolipin (CL) oxidation is a pro-apoptotic function of Cytc. Native Cytc
possesses a low degree of peroxidase activity, which increases when CL binds to Cytc
causing partial unfolding 96. To assess peroxidase activity of Cytc, the rate of Amplex Red
oxidation by CL-peroxide was analyzed in the presence of H2O2. H2O2 is a poor substrate
for Amplex Red oxidation whereas oxidized CL species are good substrates. At higher
tetralinoleyl-CL(TOCL)/Cytc ratios Thr28Glu Cytc showed significantly reduced
peroxidase activity compared to WT (Figure 2H). Interestingly, the Thr28Ala mutant had

39

the highest peroxidase activity at all ratios, suggesting that it unfolds more easily
compared to WT and Thr28Glu Cytc.
2.3.5 High resolution X-ray crystallography and molecular dynamics reveal
structural features of the Thr28 epitope.
In order to gain a better understanding of the structure-function relationship of
the Thr28 epitope we crystalized all three mouse Cytc variants under oxidizing conditions
and obtained crystals that diffracted at a resolution of 1.12 Å, 1.36 Å, and 1.30 Å for WT,
Thr28Ala, and Thr28Glu Cytc. The WT structure has the highest resolution of any
mammalian Cytc structure. As expected, the crystal structures of WT, Thr28Ala and
Thr28Glu are overall similar (Figure 3A, D, and G and Supplemental Table 1). To explore
possible differences in their solution structures, molecular dynamics simulations were
performed on the A-chain from the three protein structures as well as on a model of
phosphorylated Cytc with the phosphate group added to Thr28 in the WT chain-A using
-chain from the final solution
structure after 200 ns superposed well with the beginning crystal structure except for the
Thr28-containing loop 22-30 (Fig. 3: A, B, D, E, G, H, J, and K), which also had the highest
root mean square fluctuations (RMSF) except for the N- and C-termini (Figure 3C, F, I,
and L). In all 4 simulations, the surface loop adopted an alternate conformation, which
moved the C atom of residue 28 about 5 Å from its starting position. Surprisingly, in the
Thr28Ala simulation, the loop paused at the same conformation as the others but then
continued to move until it reached a conformation after 200 ns that put Ala28 11.9 Å from
its starting position (Figure 3E). These differences may explain the structural instability of
this mutant. In contrast Thr28Glu Cytc recapitulates the functional effects seen with in
vivo phosphorylated Cytc. As expected, electrostatic potential (ESP) calculations show
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that the Thr28Glu mutant has a negative ESP region that is larger than WT and only
exceeded by the Thr28Tpo model (Supplemental Figure 4B, C, and D).
2.3.6 Introduction of Thr28Glu cytochrome c into cytochrome c double knockout
cells reduces oxygen consumption rate, the mitochondrial membrane potential,
and ROS.
To test the effect of phosphomimetic substitution of Cytc on mitochondrial
parameters in intact cells we generated stably transfected cell lines, transfected with
empty vector (EV) control and WT, Thr28Glu, and Thr28Ala Cytc, using mouse lung
fibroblast in which both the somatic and testes-specific Cytc isoforms have been knocked
out. Double knockout is required since cultured cells lacking somatic Cytc induce the
expression of the testes isoform, restoring mitochondrial respiration 77. Expression levels
of WT and Thr28Glu Cytc were comparable between different clones whereas protein
levels of Thr28Ala Cytc was less compared to the other Cytc variants (the clone with the
highest expression levels was used for subsequent experiments, Figure 2I), suggesting
that higher expression levels of this mutant may interfere with cellular functions or that
protein turnover is higher. As previously reported, Cytc knockout interferes with complex
I and IV assembly

97,

which is reduced upon reintroduction of the three Cytc variants

(Figure 2I). Determination of cell growth showed that WT and Thr28Glu Cytc expressing
cells grew equally well whereas Thr28Ala Cytc expressing cells showed a 27% reduced
growth rate versus WT (Fig. 2J) (see Discussion). We first analyzed intact cell respiration.
Strikingly, cells expressing Thr28Glu phosphomimetic Cytc showed 60% reduced
respiration rates (Figure 2K) matching those results obtained with purified CcO in vitro
(Figures 1C and 2C). This finding is of importance because it suggests that a modification
of the small electron carrier Cytc can control overall flux in the ETC, a scenario that has
not been reported or considered in the past. Consequently, a reduction of the respiration
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rate should translate into a reduced mitochondrial membrane potential m. Analysis with
the voltage-dependent probe JC-1 showed that Thr28Ala and Thr28Glu expressing cells
showed 15% and 31% reduced fluorescence compared to WT (Figure 2L), indicating a
reduction of m. Given the direct connection of m with ROS production at complexes
I and III

98,

we predicted that Thr28Glu expressing cells should exhibit reduced ROS

levels. Using the mitochondrial ROS probe MitoSox we found that fluorescent signals
were reduced by 35-40% in cells expressing Thr28Glu and Thr28Ala Cytc compared to
WT, indicating reduced ROS levels (Figure 2M). ATP levels were reduced by 6% and
28% for cells expressing Thr28Ala and Thr28Glu, respectively (Figure 2N). To test if cells
expressing Thr28Glu Cytc are better protected from H2O2 exposure, cell viability was
determined after treatment with H2O2. Thr28Glu Cytc expressing cells showed higher
viability when treated with low concentration of H2O2, but viability matched with WT Cytc
expressing cells at higher H2O2 concentration (Figure 2O). This observation suggests that
Thr28Glu Cytc protects the cells from mild oxidative stress. These data suggest that
modification of Cytc Thr28 regulates ETC flux, which in turn affects m and ROS.
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Figure 2. Phosphomimetic Thr28Glu cytochrome c shows unique features in vitro
and after reintroduction into cytochrome c double knockout cells.
(A) Coomassie gel of bacterially overexpressed and isolated wild-type (WT), Thr28phosphorylated Cytc (pT28), Thr28Glu (T28E), and Thr28Ala (T28A) Cytc indicates that
the proteins were purified to homogeneity.
(B) Redox potential is reduced in the Thr28Glu and Thr28Ala mutants compared to WT.
(C) O2 consumption rates of Cytc in the reaction with cow cytochrome c oxidase were
73% and 51% reduced for Thr28Glu and Thr28Ala Cytc.
(D) In vitro caspase 3 activity is unaltered in Thr28Glu Cytc whereas it is increased with
the Thr28Ala mutant.
(E) Oxidation rate of WT and Thr28Glu Cytc in the presence of H2O2 is similar whereas
the Thr28Ala mutant shows increased rates.
(F) Compared to WT, loss of the heme group by excess H2O2 is decreased and increased
for Thr28Glu and Thr28Ala Cytc, respectively. Shown are representative heme
destruction curves.
(G) Thr28Glu Cytc reduction rate in the presence of ascorbate is increased compared to
WT and Thr28Ala Cytc.
(H) Thr28Glu Cytc-mediated cardiolipin oxidation is decreased at highest TOCL/Cytc
ratios compared to WT and Thr28Ala Cytc.
(I) Western blot of Cytc double knockout lung fibroblasts stably transfected with empty
vector (EV) and WT, Thr28Ala, and Thr28Glu expression constructs.
(J) Proliferation rates of stably transfected lines were determined by cell counts.
(K) Intact cell oxygen consumption rates (OCR) are decreased in both Cytc mutants.
(L) Mitochondrial membrane potential as determined by JC-1 fluorescence was
decreased in cells expressing Thr28Glu versus WT and Thr28Ala Cytc.
(M) Basal mitochondrial reactive oxygen species generation as determined with MitoSOX
is decreased in cells expressing Thr28Glu Cytc compared to WT.
(N) ATP levels determined with the bioluminescent method were decreased in cells
expressing Thr28Glu Cytc compared to WT.
(O) Live cell counts after treatment with H2O2 indicate that Thr28Glu expressing cells are
better protected at intermediate H2O2 levels compared to WT whereas Thr28Ala
expressing cells show decreased survival at all concentrations.
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Figure 3. Structural and molecular dynamics analyses.
(A) Chain-A from the WT crystal structure (5C0Z.pdb) before (green) and after (cyan) 200

39 intermediate 5 ns steps between the two endpoints are shown as spheres colored in
a gradient from gray (5 ns) to red (195 ns).
(B) The mobile loop (amino acids 22-30) from Figure 3A is shown in higher detail after
rotation by 90° about its horizontal axis to generate a “bottom-up”
atoms (gray to red) all cluster about T28* showing that the loop jumps immediately to its
minimum energy position and stays there. The distance between T28 C and T28* C
is 4.5 Å.
(C) The root mean square fluctuations (RMSF) for the first 100 ns (blue line) and the
second 100 ns (red line) by residue are plotted together. Two RMSF values in the first
100 ns (Lys27, Ala44) are noticeably lower in the second 100 ns.
(D) Chain-A from the T28A crystal structure (5C9M.pdb) before (green) and after (cyan)
200 ns of molecular dynamics. See Figure 3A for details.
(E) Equivalent to Figure 3B except the two loops are from Figure 3D. Over the 200 ns,
the C atom of Ala28 pauses at 4 distinct intermediate positions before clustering around
the final position. The distance between A28 C and A28* C is 11.9 Å.
(F) Equivalent to Figure 3C for T28A Cytc. The RMSF values for Ala44 are lower in the
second 100 ns but those for Lys27 are significantly higher in the second 100 ns, in fact
the highest seen in all four RMSF plots.
(G) Chain-A from the T28E crystal structure (5DF5.pdb) before (green) and after (cyan)
200 ns of molecular dynamics. See Figure 3A for details.
(H) Equivalent to Figure 3B except the two loops are from Figure 3G. Over the 200 ns,
near the end of the simulation. The distance between E28 C

and E28* C

is 7.2 Å.

(I) Equivalent to Figure 3C for T28E Cytc. The RMSF values for Ala44 are of average size
and similar for both halves of the simulation. The RMSF values for the loop containing
Glu28 are higher than average but similar for both halves of the simulation.
(J)
-A from the WT crystal structure (5C0Z.pdb) with a phosphate
group modeled onto Thr28 are shown superposed before (green) and after (cyan) 200 ns
of molecular dynamics. See Figure 3A for details.
(K) Equivalent to Figure 3B except the two loops are from Figure 3J. Over the 200 ns
period, the C atom of Tpo28 moves quickly to the final position and clusters around it.
The distance between X28 C and XT28* C is 5.2 Å.
(L) Equivalent to Figure 3C for the T28PO model. The RMSF values for the loop
containing Glu28 are higher than average but similar for both halves of the simulation.
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2.3.7 AMPK interacts with and phosphorylates cytochrome c on Thr28
To identify a kinase candidate that targets Cytc for Thr28 phosphorylation we
first used the online tool Scansite 99 for in silico prediction of possible Cytc binding motifs
of signaling molecules. Interestingly, Thr28 was predicted to be an AMPK phosphorylation
site. To test this possibility we first performed an in vitro kinase assay with commercially
available AMPK and unphosphorylated WT Cytc as substrate to see if this reaction can,
in principle, take place. As shown in Figure 4A, Cytc was phosphorylated in a specific and
AMPK-dependent manner, which could be further accelerated by addition of AMPK
activator AMP (Figure 4B). We next confirmed by mass spectrometry that Thr28 was the
site of in vitro AMPK phosphorylation (Figure 4C). In order for AMPK to phosphorylate
Cytc in kidney the proteins have to physically interact inside the cell. Under basal
conditions, co-immunopreciptation experiments using extracts from total mouse kidney
tissue as well as highly purified mitochondria shows interaction of AMPK with Cytc (Figure
4D). Furthermore, submitochondrial fractionation of highly purified mitochondria indicates
that AMPK and its activated phosphorylated form is present in the mitochondrial
intermembrane space (Figure 4E, lane 2), as is Cytc. Finally, activation and inhibition of
AMPK in mouse kidney tissue using A769662 and Compound C, as confirmed by
phosphorylation of AMPK target phospho-acetyl-CoA carboxylase (Figure 4F), results in
increased and decreased threonine phosphorylation of Cytc, respectively (Figure 4G),
which inversely correlates with intact mitochondrial respiration rates (Figure 4H), mirroring
data presented in Figures 1 and 2. It is important to note that no such effects were
observed using liver tissue (data not shown), suggesting tissue-specific differences in the
regulation of Cytc, which agrees with our previous studies demonstrating that liver Cytc
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is Tyr48 phosphorylated.
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Figure 4. AMPK interacts with and phosphorylates cytochrome c on Thr28.
(A) In vitro AMPK kinase assay with cow heart Cytc, conducted in the absence of AMPK
activator AMP, shows a time-dependent increase of threonine phosphorylation as
determined by Western analysis.
(B) In vitro AMPK kinase assay with cow heart Cytc shows an increase of threonine
phosphorylation in the presence of AMPK activator AMP.
(C) Cytc subjected to in vitro AMPK kinase assay as in (A) is phosphorylated on Thr28 as
determined by the Nano-LC/ESI/MS/MS spectrum of HKpTGPNLHGLFGR. The
phosphorylation site was unambiguously assigned by fragment ions y10 and y11. The
sequence of the peptide was assigned by b2, b8, b9, y2, y5, y6, y8, y9, and y10.
(D) Immunoprecipitation (IP) of AMPK from total mouse kidney extracts and purified
mitochondrial extracts shows interaction of AMPK with Cytc.
(E) Submitochondrial fractionation of sucrose gradient purified mouse kidney
mitochondria shows AMPK and p-AMPK localization to the mitochondrial intermembrane
space (IMS). Lane 1, mitochondrial lysate; lane 2, intermembrane space; lane 3, pellet
after outer mitochondrial membrane permeabilization containing outer mitochondrial
membrane, mitoplasts and residual IMS; lane 4, kidney tissue homogenate.
(F) Incubation of mouse kidney tissue with AMPK activator A769662 and inhibitor
Compound C leads to activation and inhibition of AMPK, respectively, as deduced by
AMPK target phospho-acetyl-CoA carboxylase (p-ACC).
(G) Pull-down of Cytc from mouse kidney tissue after treatment with AMPK activator
A769662 and inhibitor Compound C leads to an increase and decrease of Cytc threonine
phosphorylation, respectively.
(H) Incubation of mouse kidney tissue with AMPK activator A769662 and inhibitor
Compound C leads to decreased and increased intact mitochondrial respiration as
determined in tissue homogenates.
(I) Model of the regulation of electron transport chain activity through phosphorylation of
Cytc. Under healthy conditions Cytc is phosphorylated, leading to a partial inhibition of
mitochondrial respiration. This in turn maintains healthy intermediate membrane
mitochondrial potentials (m) that are sufficient for effective energy production but
prevent the generation of ROS, which occurs at pathologically high m values.
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2.4 Discussion and summary
Very little is known about the regulation of mitochondrial oxidative
phosphorylation by cell signaling. We have previously reported two distinct tyrosine
phosphorylation sites on Cytc from mammalian heart and liver tissue. The current report
functionally characterizes a third tissue-specific phosphorylation site, Thr28 mapped on
Cytc purified from kidney. The same site was also mapped, but not further studied, in a
high-throughput mass spectrometry study using resting human skeletal muscle

100,

suggesting that Thr28 can be targeted to regulate ETC function beyond kidney tissue.
Here, we have isolated Cytc from kidney in which the majority (between 60-80%,
depending on the preparation) of the protein is phosphorylated at Thr28. In addition, we
have mutated Thr28 to glutamic acid, a phosphomimetic amino acid, and alanine, a nonphosphorylatable control mutation, to further characterize the effects of this
phosphorylation in vitro and in cultured murine lung fibroblast cells lacking both Cytc
isoforms, the only Cytc double knockout cell line available.
Bovine in vivo phosphorylated and unphosphorylated Cytc as well as
overexpressed mouse WT, Thr28Glu, and Thr28Ala Cytc generated hyperbolic kinetics
in the reaction with purified bovine liver CcO. All Cytc species exhibited KM values from 4
to 10 micromolar. Maximal turnover was reduced by 50% and 73% for in vivo
phosphorylated and phosphomimetic Cytc, respectively. Furthermore, expression of
phosphomimetic Thr28Glu Cytc led to a reduction of respiration in intact cells suggesting
for the first time that modification of the small electron carrier can control overall ETC flux.
These findings are consistent with the concept that phosphorylation of mitochondrial
proteins, in general, down-regulates whereas dephosphorylation activates mitochondrial
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function

101.

Reduced respiration rates both in vitro with purified CcO and in intact cells

expressing Thr28Glu Cytc may be a result of the observed change in the redox midpoint
potential as well as structural changes of the protein. Thr28 lies in the center of an unusual
structural element termed “negative classical gamma turn,” which is composed of
residues 27-29 and important for the stability of Cytc 102. Thr28 is a surface residue close
to the solvent exposed and accessible tip of the heme group that mediates electron
transfer to CcO. It is located on the frontal right side of the molecule in the conventional
view (Figure 3A), which is part of the circular, positively charged epitope surrounding the
heme crevice with which Cytc binds to the corresponding negatively charged epitope on
CcO

12.

Interestingly, in this computational Cytc-CcO docking model, Thr28 is located at

the interface of catalytic subunits I and II and nuclear encoded subunit VIIc, with closest
distances of <6Å with Lys47 of subunit VIIc, and of <7Å with Asp50 of subunit I and
Trp104 and Ser202 of subunit II (Supplemental Figure 4G). Two of the four CcO residues
are particularly noteworthy. Asp50 is one of only a handful of residues in the entire CcO
complex that have noticeably different geometries between the reduced and oxidized
state in the crystal structure 103. In addition, Asp50 is located next to another flexible amino
acid, Asp51, which, when mutated to Asn, blocks proton pumping of the enzyme and was
proposed to be the proton ejection site of CcO 104. Phosphorylation of Thr28 may interfere
with the outward movement of the Asp50-Asp51 region and thus the opening of the
proposed proton exit channel during reduction of CcO. This would lead to inhibition of
CcO by inhibiting electron transfer-coupled proton pumping. Alternatively, repulsion
between phospho-Thr28 and Asp50 may result in suboptimal binding to CcO, causing
reduced respiration rates. The second interesting interaction site on CcO is Trp104, which
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is the site of CcO where electrons from Cytc enter CcO before reaching the first metal
center, the binuclear CuA site. Spatial interference upon Cytc Thr28 phosphorylation with
Trp104, which is essential for catalysis, could also explain reduced activity. Analogous
considerations may also be applicable for the interaction of Cytc with bc1 complex.
We have previously shown that phosphomimetic Tyr48Glu Cytc is incapable of
downstream caspase activation

75.

In contrast, phosphorylation of Cytc Thr28 or its

phosphomimetic substitution does not interfere with the ability of Cytc to trigger
downstream caspase activation. This difference agrees with the observation that the
Tyr48 epitope is directly involved in the interaction of Cytc with Apaf-1, whereas the Thr28
epitope is not 105.
We observed threonine phosphorylation of Cytc from kidney but not from liver
tissue, where Cytc is phosphorylated on Tyr48 under basal conditions
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Signaling

molecules including AMPK are expressed in a tissue-specific manner, which may in part
explain tissue-specific differences in cell signaling. Trimeric AMPK consists of three
subunits, each of which composed of several isoforms. The primary isoforms found in
kidney are 1, 1 and 2, and 1 and 2

106.

Future work should identify which AMPK

subunit composition is present in kidney mitochondria. Cell signaling also operates
differently in different organisms. Ser/Thr/Tyr-phosphorylations are most common in
mammals whereas His/Arg/Lys/Asp-phosphorylations are common in bacteria but not in
mammals. A recent study compared 285 Cytc sequences across all phyla from humans
to bacteria

107.

Overall, threonine is the most common amino acid at position 28 and

conserved in mammals. However, in some non-mammalian organisms five other amino
acids can also be found, namely Gln, Val, Ile, Ser, and even the phosphomimetic Glu,
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which is present in several plants including potatoes and tomatoes. Interestingly, alanine
is not among the residues evolutionarily tolerated in this position. We found that Thr28Ala
Cytc has a higher ability to activate downstream caspases and unfolds more easily, which
increases CL oxidation. Its instability compared to WT and Thr28Glu Cytc is also
suggested in the respective circular dichroism spectra (Supplemental Figure 1C, see
lower wavelength range). In addition, Thr28Ala Cytc is most rapidly oxidized and
degraded in the presence of H2O2. These features of the Thr28Ala mutant may explain
why it was evolutionarily selected against. Structural analysis of all three Cytc variants
shows that the amino acids comprising the negative classical gamma turn element display
by far the highest root-mean-square deviation values compared to any other Cytc
sequence, suggesting that the Thr28 epitope is the most flexible element of the entire
molecule. A plot of the average temperature factors, which for these high resolution
structures are a reasonable measure of local mobility, also showed that the highest
relative values, other than at the termini, occurred at the 22-30 loop for all three structures.
Furthermore, molecular dynamics simulations of crystalized Thr28Ala Cytc produce a
structure in which the Thr28 C atom is moved by 11.9 Å, over twice as far compared to
WT, Thr28Glu, and modeled phospho-Thr28 Cytc (Figure 3). These findings collectively
suggest that alanine was evolutionarily selected against, since it introduces additional
flexibility, likely due to its small size, at a site near the heme crevice leading to a
detrimental reduction of protein stability and interference with its multiple functions. This
may also at least in part account for the finding of lower Cytc protein levels in cells
expressing this mutant. Another evolutionarily forbidden substitution,Thr28Asp, which
introduces a negative charge, also generates “rogue” functional changes in Cytc as seen
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in the reaction with CcO that are even opposite
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of what we report with in vivo

phosphorylated Cytc, while glutamate replacement as used here, produces the same
functional effects as phosphorylated Cytc. These findings collectively suggest that some
amino acids such as alanine and aspartate were evolutionarily selected against, since
they alter the functions of Cytc. Alanine replacement introduces additional flexibility, likely
due to its small size, at a site near the heme crevice leading to a detrimental reduction of
protein stability and interference with its multiple functions. This may also at least in part
account for the finding of lower Cytc protein levels in cells expressing this mutant.
Our studies suggest that AMPK targets Cytc for Thr28 phosphorylation within
the mitochondria. AMPK is one of the most important and evolutionarily oldest metabolic
sensors and regulators 109. It is implicated in human disease including diabetes, where its
activity is impaired in several organs including the kidneys 110. Generally, AMPK promotes
catabolic processes, and it is activated by phosphorylation and allosterically under
conditions when ATP levels drop and AMP levels increase. However, our understanding
of the role of AMPK specifically in the kidney is in its infancy

111,

and there are reports

suggesting that it operates differently in this organ compared to other tissues. For
example, AMPK is already active in kidney under basal conditions and shows a
paradoxical decrease in activity in a rat kidney ablation and infarction model

112,

a

condition when energy depletion and thus demand is maximal. In cells from patients with
hereditary leiomyomatosis renal cell cancer, the Krebs cycle is inhibited, which also leads
to a paradoxical decrease of AMPK activity

113.

The high basal activity of AMPK also

observed in this study (Figure 4F) may be due to the fact that kidneys are always active
and rely heavily on oxidative phosphorylation 93. Consistent with our findings that AMPK-
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mediated Cytc phosphorylation partially suppresses mitochondrial respiration, it was
shown in human renal proximal tubular epithelial cells that additional activation of AMPK
with metformin results in a significant reduction of cellular respiration

114.

We propose a

model, shown in Figure 4I, that a central role of Cytc Thr28 phosphorylation in kidney is
to maintain optimal intermediate m levels, which allow efficient energy production but
prevent ROS generation because ROS are produced at high m levels (reviewed in 115.
In line with our concept, it was shown in rats subjected to renal ischemia/reperfusion injury
that application of a high dose of AMPK activator AICAR shortly before ischemia
significantly improves cell survival

116.

Cytc purified from ischemic kidney is

dephosphorylated (not shown) similar to Cytc isolated from ischemic brain 71. This would
allow maximal ETC flux, m hyperpolarization, and ROS production during reperfusion
when ETC function is reinstated due to reintroduction of oxygen. We have shown that
neuroprotective insulin treatment prior to brain ischemia/reperfusion leads to Cytc Tyr97
phosphorylation, which also decreases respiration, resulting in suppression of the release
of Cytc from the mitochondria, and a 50% reduction of neuronal death

71.

It will be

interesting to see in future studies if AICAR treatment maintains Cytc Thr28
phosphorylation during ischemia in kidney, alleviating ETC hyperactivation during
reperfusion.
In conclusion, all three functionally studied Cytc phosphorylations to date,
Tyr97, Tyr48, and Thr28, lead to a partial inhibition in the reaction with CcO, or ‘controlled
respiration’ (Figure 4I). We propose that this mechanism provides a basis for the
maintenance of ‘healthy’ intermediate m levels under normal conditions. This, in turn,
prevents excessive ROS production that occurs at high m levels under conditions of
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stress when mitochondrial proteins become dephosphorylated, allowing maximal ETC
flux, m hyperpolarization, excessive ROS, and cell death. Although all 3 known Cytc
phosphorylations limit respiration, the choice of site in a particular tissue may depend on
tissue-specific metabolic differences or on additional effects of the phosphorylation, such
as the participation of Cytc in apoptosis.
2.5 Supplemental Figures

Supplemental Figure 1A. Alignment of mammalian somatic (top) and testes (T, bottom)
Cytc sequences. Conserved amino acids are highlighted in yellow. Thr28 is highlighted
in bold print. Accession numbers: NP_061820 (human); NP_001157486 (horse);
NP_001039526 (cow); NP_001123442 (pig); NP_001183974 (dog); CAA25899 (mouse);
NP_036971 (rat); EPQ18492 (bat); AJF48831 (goat); AFN27378 (dolphin); AAI02715
(bull testes); AAH59728 (mouse testes); NP_036972 (rat testes).
Abs
0.75

0.5

0.25
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Supplemental Figure 1B. Spectral analysis of overexpressed and purified reduced WT
(blue), Thr28Ala (green), Thr28Glu (red), and cow heart Sigma Cytc as control (cyan)
indicates correct folding and functionality of the proteins.

WT

Thr28Glu

Thr28Ala

SCC

Supplemental Figure 1C. Circular dichroism spectra are similar for WT, Thr28Glu, and
Sigma Cytc (SCC), whereas the Thr28Ala mutant shows spectral differences as lower
wavelengths.

(% of unphosphorylated Cytc)

Caspase activation
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Supplemental Figure 2. Unphosphorylated (WT) and in vivo phosphorylated (pT28) Cytc
have a similar ability to induce caspase 3 activation in a cell free caspase assay.
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Supplemental Figure 3.
(A) Residues and water molecules near Thr28 in the WT protein (green carbon atoms)
are shown with their electron density contoured at one sigma. To minimize the effects of
differing side chain lengths and to make this figure for WT comparable to those for T28A
and T28E, it includes all groups within 4 Å of Glu28 superposed onto Thr28. The heme
(PDB code Hec) groups have magenta carbon atoms for contrast. The covalent links from
Cys17 SG to the Hec vinyl groups (see Supplemental Table 1) are shown as black
dashes. Hydrogen bonds are indicated with gray dashed lines.
(B) Equivalent to (A) above but for the T28A structure (5C9M.pdb), residues and water
molecules near Ala28 (green carbon atoms) are shown with their electron density
contoured at one sigma. To make this figure for T28A comparable to those for WT and
T28E, it includes all groups within 4 Å of Glu28 superposed onto Ala28. Ile81/A, which is
shown in Fig. 3xA and 3xC is omitted here because it was 4.1 Å from Glu28 in the
superposed structure of T28E.
(C) Equivalent to A above but for the T28E structure (5DF5.pdb), residues and water
molecules within 4Å of Glu28 (green carbon atoms) are shown with their electron density
contoured at one sigma. The terminal oxygen atoms of the two Glu28 residues share two
hydrogen bonds (2.72 & 3.25 Å) and are presumed to be protonated.
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G

Supplemental Figure 4.
(A) Average B-Factors. The average temperature factor (B-factor) for the main chain
atoms in WT (black), Thr28Ala (red), and Thr28EGlu (blue) are shown plotted by residue
position.
(B) The negative (red) and positive (blue) electrostatic potential (ESP) are shown
contoured at 20 kcal/mole for the WT protein shown as a “tube” tracing. The side chain
atoms (magenta) of Thr28 are shown as balls. The ESP was calculated by YASARA using
the recommended Nova force field in vacuo at pH 7.4. The ESP plot for the T28A mutant
(not shown) is indistinguishable from this figure.
(C) The negative (red) and positive (blue) electrostatic potential (ESP) are shown
contoured at 20 kcal/mole for the T28E mutant shown as a “tube” tracing. The side chain
atoms (magenta) of Glu28 are shown as balls. The ESP was calculated by YASARA using
the recommended Nova force field in vacuo at pH 7.4.
(D) The negative (red) and positive (blue) electrostatic potential (ESP) are shown
contoured at 20 kcal/mole for the phosphor-Thr model (Tpo28) shown as a “tube” tracing.
The side chain atoms (magenta) of Tpo28 are shown as balls. The ESP was calculated
by YASARA using the recommended Nova force field in vacuo at pH 7.4.
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(E) The entire WT “tetramer” in the unit cell of space group P1 is shown with its six
hexacyanoferrate(3-) ligands (PDB code FC6) identified with “X” as a one letter code in
this figure. X202a&b/A and X203a&b/B are pairs of FC6 ligands with partial occupancies
and alternate positions (Supplemental Table 1) that physically overlap with each other
and cannot be occupied simultaneously. The ESP was calculated by YASARA using the
recommended Nova force field in vacuo at pH 7.4. The T28A tetramer, which is not
shown, was crystallized under the same conditions as the WT protein, and has very
similar FC6 ligands (Supplemental Table 1) and the same ESP contours.
(F) The entire T28E “tetramer” in the unit cell of space group P1 is shown with its three
hexacyanoferrate(3-) ligands (PDB code FC6) identified with “X” as a one letter code. The
ESP was calculated by YASARA using the recommended Nova force field in vacuo at pH
4.5. Given the close proximity and presumed hydrogen bonding between pairs of Glu28
residues (Supplemental Figure 3C) their pKa values were manually set to 7.0 so they
would be protonated during the calculation of the ESP.
(G) Docking model of Cytc and CcO 12. Residues on CcO within a distance of 7 Å from
Thr28 (red) are highlighted (Lys47 of CcO subunit 7c, magenta; Asp50 of CcO subunit I,
yellow; Trp 104, green, and Ser 202, cyan, of CcO subunit II).

Supplemental Table 1. Crystallographic Data1
CYTC (WT)

CYTC (T28A)

CYTC (T28E)

CYTC (Y47F)

MOUSE

MOUSE

MOUSE

HUMAN2

5C0Z

5C9M

5DF5

3ZOO

Oxidized

Oxidized

Oxidized

Oxidized

STRUCTURE

PDB CODE
CRYSTALLIZAT
ION
Iron

12.5
Protein

mg/mL

15 mg/mL Cytc 22 mg/mL Cytc 15 mg/mL Cytc
oxidized protein
(WT) + 5 mM (T28A) + 5 mM (T28E) + 5 mM
in 22.5% (w/v)
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K3Fe(CN)6

in K3Fe(CN)6

in K3Fe(CN)6

water

water

water

in PEG 1000, 50
mM KH2PO4, pH
7.0

25% PEG 4K, 25% PEG 4K,

26-31%

(W/V)

8% isopropanol, 8% isopropanol, 30% PEG 1500, PEG 1000, 40
Well
0.1

Drop

M

Na 0.1

M

Na pH 4.5

acetate, pH 6.5

acetate, pH 6.5

1:1 protein:well

1:1 protein:well

mM, KH2PO4 pH
7.0

1:1 protein:well

n/a

30% PEG 4K, 30% PEG 4K,
8% iso propanol, 8% iso propanol,
0.1M Na acetate, 0.1
Cryoprotectant

20%

M

ethylene acetate,

26-31%

(w/v)

Na 35% PEG 1500, PEG 1000, 40
20% 20%

ethylene mM, KH2PO4 pH

glycol, 10 min ethylene glycol, glycol

7.0,

soak with 5 mM 10 min soak with

glycerol

K3Fe(CN)6

5 mM K3Fe(CN)6

Space group:

P1

P1

P1

P1

Unit cell: a

34.401

34.517

34.609

36.367

b

52.471

52.567

51.739

53.952

c

61.647

61.771

61.748

58.95

CRYSTAL DATA

15%
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Alpha

110.04

109.86

110.01

76.55

Beta

92.77

92.93

93.09

88.73

Gamma

92.02

92.20

91.88

71.86

4

4

4

2.24

2.27

2.25

2.3

45.12

45.7

45.26

46.7

1.124

1.36

1.30

1.35

49.22

57.96

57.88

30.59

Chains per A.U. 4
Matthews
Coeff.
Solvent %
X-RAY DATA
Resolutionhigh (Å)
Resolution-low
(Å)

DIAMOND
Beamline

APS 21-ID-F

APS 21-ID-F
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APS 21-ID-D
(UK)

Wavelength

0.97872

0.97872

1.07812

0.9762

Reflections

127840

76544

90455

81707

Completeness

87.4 (44.66)

92.4 (66.2)

96.6 (89.38)

94.73 (80.71)
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Average
14.4 (2.0)

14.1 (2.2)

14.9 (2.4)

8.70 (n/a)

Redundancy

3.9 (3.7)

3.9 (3.8)

5.3 (4.2)

n/a

Rmerge

0.05

0.052 (0.580)

0.081 (0.504)

0.07

Rfactor

0.132 (0.239)

0.129 (0.229)

0.148 (0.256)

0.13821

Rfree

0.159 (0.240)

0.170 (0.303)

0.178 (0.252)

0.17935

15.97

21.41

19.32

17.703

3228

3220

3236

3981

537

472

334

417

Bond RMSD

0.017

0.016

0.018

0.017

Angle RMSD

1.903

1.803

1.884

1.99

Chiral RMSD

0.124

0.122

0.131

0.125

I/sigma

REFINEMENT

Avg.

B-factor

(Å2)
Protein

atoms

per A.U.
Water
molecules

FC6
OCCUPANCY
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202a/A

0.28

0.35

–

202b/A

0.37

0.34

–

202/B

0.93

0.98

0.92

203/B

–

–

0.48

203a/B

0.30

0.39

–

203b/B

0.32

0.28

–

202/C

0.90

1.00

0.89

Chain-A

1.86

1.92

1.91

1.93

Chain-B

1.86

1.93

1.90

1.96

Chain-C

1.91

1.94

1.95

1.96

Chain-D

1.95

2.02

1.94

1.93

Average

1.90

1.95

1.93

1.95

1.98

2.09

1.96

2.06

HEME LINKS:
C14 SG - HEM
CAB (Å)

C17 SG - HEM
CAC (Å)
Chain-A

68

Chain-B

1.94

2.07

1.99

2.21

Chain-C

1.97

2.12

2.07

2.16

Chain-D

2.04

2.21

2.06

2.08

Average

1.98

2.12

2.02

2.13

Chain-A

2.02

2.03

2.00

2.00

Chain-B

2.03

2.00

2.02

2.06

Chain-C

2.02

2.04

2.03

2.01

Chain-D

2.01

2.07

2.02

2.02

Average

2.02

2.04

2.02

2.02

Chain-A

2.29

2.27

2.28

2.29

Chain-B

2.28

2.27

2.27

2.29

Chain-C

2.30

2.28

2.30

2.24

Chain-D

2.31

2.27

2.29

2.29

Average

2.30

2.27

2.29

2.28

H18 NE2 - FE2
(Å)

M80 SD - FE2
(Å)
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1All

three structures have 4 molecules in a P1 unit cell with very similar
dimensions. When the twelve independently refined Cytc molecules are overlapped with
each other using their main chain atoms, the average RMSD value among the 66 unique
pairs is 0.189 Å, and the highest value is 0.280 Å between chain-A in WT and chain-D in
Thr28Glu. Comparing equivalent chains, the three A-chains have the smallest RMSD
(0.080 Å) followed by the B-chains (0.107 Å), the D-chains (0.0.113 Å) and the C-chains
(0.140 Å). The three Cytc “tetramers” reported here have a similar orientation in the P1
unit cell. The Thr28Ala and Thr28Glu mutants have RMSD values, based on backbone
atoms, of 0.151 Å and 0.330 Å, respectively, when superposed on the WT structure as
tetramers. The Thr28Ala structure is more similar to the WT structure because it was
crystallized at pH 6.5 from the exact same conditions as the WT protein, whereas the
Thr28Glu mutant was crystallized from a different solution at pH 4.5. The Thr28Glu
mutant only crystallized at pH 4.5 because the four Glu28 residues, are arranged in
closely adjacent pairs in the “native” tetramer and destabilizes the crystal packing if they
are deprotonated (see Supplemental Figures 3 and 4). The Thr28Glu crystal structure
has the same two major FC6 ligands (FC6 202/B and FC6/C), as the WT structure and a
third, unique site (FC6 203/B), which is possibly related to the lower pH. It has no
significant density for the two minor sites (FC6 202/A and FC6 203/B) in the WT and
Thr28Ala crystal structures. The lower occupancies of the minor FC6 sites suggest they
are weakly bound and were probably lost from the Thr28Glu crystals during the crystal
freezing procedure, which used a cryo-solution soak that did not include the FC6 reagent.
2Mouse

and human Cytc monomers are similar but their tetramers differ: The
mouse WT structure was solved using chain-A from the crystal structure of human Cytc
(see Methods), and the two refined chains have a RMSD of 0.266. Also, the three mouse
structures, like the human structure, were solved and refined using the free heme moiety
(PDB ligand code: HEM) and finished with very similar, unconstrained bond distances for
the dative bonds to heme iron and the covalent links to Cys14 and Cys17. In contrast, the
tetramers observed in both crystal structures, have a RMSD overlap of 17 Å because the
Cytc molecules have very different orientations within the tetramer (not shown). The
tetramers are crystal entities and do not exist in solution. All three Cytc monomers – WT,
Thr28Ala, Thr28Glu – have a region with strong positive electrostatic potential (ESP)
(Supplemental Figure 4E and F). In the three structures reported here, the monomers are
arranged with their positive ESP regions adjacent to each other in pairs. This arrangement
is possible because the FC6 ligands with their -3 charge balance the strong positive ESP.
The human Cytc lacks these ligands. Consequently, the monomers are rotated within the
human tetramer so the ESP potentials are distant from each other (not shown).
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CHAPTER 3 SUMMARY
To understand how Cytc phosphorylation is induced under stressed conditions,
and how it functions in protecting tissues affected by that stress, we performed a second
study where the phosphorylation status of Cytc in ischemic brain was investigated. The
following article demonstrates how insulin-induced neuroprotection and inhibition of Cytc
release under conditions of brain ischemia was connected to Cytc phosphorylation. Our
data suggest that phosphorylation of Cytc occurs in an insulin-dependent manner, and
significantly reduces induction of apoptosis via prevention of Cytc release from
mitochondria (manuscript published in PLoS One, 2013 8(11):e78627).
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CHAPTER 4 CONCLUSIONS AND FUTURE DIRECTIONS
This dissertation set out to investigate the role Cytc phosphorylation plays in
various aspects of life, under physiologically healthy and stressed conditions, and to use
biochemical and molecular biological techniques to decipher the mechanisms affected by
it. In this final chapter, I will review the research contributions of this dissertation, as well
as discuss directions for future research.
4.1 Conclusions
The importance of cell signaling pathways in regulating protein functions have
been known for many years. Mitochondrial proteins have been known to be posttranslationally modified, altering their functions under influence from cell-signaling
pathways targeting them. The understanding of how phosphorylation of mitochondrial
electron transport chain (ETC) protein Cytc function is naturally of great importance and
was the main motivation for this thesis. The work consisted of three parts: discovering the
amino acid residue that are endogenously phosphorylated on Cytc under physiologically
healthy conditions in tissues like kidneys and brain, the effect of these phosphorylations
on the functioning of the protein, for example control of the rate of reduction, and the
transfer of electrons between complexes III and IV of the ETC, and discovering the
kinase(s) that are responsible for the phosphorylations on the protein. As models for our
study, the following proteins were used: the wild-type rat Cytc protein, the
phosphomimetic Thr28Glu Cytc mutant, and the non-phosphorylatable Thr28Ala Cytc (an
additional control). This thesis research has contributed incremental but significant results
for the continuing study of phosphorylated mitochondrial proteins, and some suggestions
for further work. Multiple studies from our laboratory showed that Cytc is tightly regulated
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by

post-translational

modifications,

especially

phosphorylation.

Site-specific

phosphorylations on Cytc were discovered in our laboratory with the help of techniques
of purification of the protein that helps in preserving the physiological phosphorylation
status of the protein, as it was present within the healthy live tissue. Cytc was previously
isolated from mammalian heart and liver tissues in our laboratory and site specific tyrosine
phosphorylations were detected by Nano/LC/ESI/MS/MS. Experiments showed that
these phosphorylations had significant impact on the various functions of the protein,
proving that phosphorylation of the protein is undoubtedly important. These results led to
our overall hypothesis that Cytc phosphorylation does regulate the two major functions of
Cytc, mitochondrial respiration and Cytc release during apoptosis. The long term goal of
our laboratory is therefore to understand the effect of Cytc phosphorylation on respiration
and apoptosis, and to identify the cell signaling pathways directed to Cytc.
This thesis research aimed at understanding Cytc phosphorylation in detail, by
investigating the project via addressing three specific aims: 1) testing the hypotheses that
Cytc is in vivo phosphorylated under physiologically healthy conditions in a distinct tissuespecific manner, 2) testing the hypotheses that phosphorylation of Cytc leads to controlled
respiration and prevents its participation in activation of the Cytc-mediated apoptosis
cascade, and 3) to systematically identify mitochondrial kinases that phosphorylate Cytc
on specific residues in a tissue-specific manner. Whether these phosphorylations result
in structural changes of the protein is under study. This thesis research discloses that the
long recognized central molecule in respiration and apoptosis, Cytc, is regulated by cell
signaling pathways that target mitochondria under healthy conditions, opening new
avenues to understand and control the two main biological processes that depend totally

73

on this small single electron carrier protein. In a follow-up study, we are analyzing
whether there are any structural changes brought about by site-specific phosphorylation,
and identify the kinases and phosphatases that phosphorylate and dephosphorylate Cytc.
Since Cytc-mediated apoptosis and cellular respiration play a crucial role in many
diseases such as cancer and neurodegeneration, this study is anticipated to provide
better understanding and control of such diseases.
Cell signaling pathways that target the mitochondria are not well defined and
are poorly understood. Major metabolic regulators that are known to affect mitochondrial
functions, such as insulin, glucagon, and calcium, have not been well studied to reveal
their mechanism of action. However, our laboratory has published protocols to isolate
mitochondria and ETC components which preserve their endogenous phosphorylation
state, and we provide compelling evidence that cell signaling pathways act on Cytc in a
distinct and tissue-specific manner. During this thesis research, we developed methods
to assess the levels of endogenous Cytc phosphorylation, and for the first time, we
identified the kinase that phosphorylates Cytc in kidney tissues under healthy conditions,
phosphorylating Cytc at Thr28 residue. We show that it is the AMP-kinase-mediated
phosphorylated form of Cytc that exists in healthy kidney tissues in vivo, and functional
studies revealed that phosphorylation on this site leads to controlled respiration, reduced
cardiolipin peroxidase activity, which is required for its release from the mitochondria
during apoptosis, and unaltered capability to induce caspase activation with Thr28
phosphomimetic Cytc. This research indicates that Thr28 site is important in the redoxfunctioning of the protein, and plays an important role in maintain the native structure and
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functions of the protein under healthy conditions, when the protein resides within the
mitochondrial intermembrane space.
4.2 Future directions
To further advance our understanding of how phosphorylation of Cytc affected
its functions under physiological conditions, several steps can be taken to address
questions that arise with this research.
4.2.1 How to better study tissue-specific phosphorylations?
Tissue-specific phosphorylations can be better studied by approaching to study
tissue-specific phosphorylations by creating animal models expressing phosphomimetic
Cytc in individual sites in tissues that they were discovered in, and comparing them with
wild type Cytc expressing animals. This will address multiple questions at the same time.
We will be able to find out how the phosphorylation of the protein alters the animal’s ability
to survive conditions which are stressful under physiological conditions.
Second, to discover the level and sites that are physiologically phosphorylated
in different tissues within one healthy animal, purification of Cytc can be performed
followed by mass spectrometry. This would give an overall understanding of the
phosphorylations that exist in a healthy animal at a time, in different tissues. Then,
changes in the phosphorylation profiles in different tissues could be studied under
different stressed conditions. Also, changes in the protein functions can also be measured
by various assays that has been performed in this thesis project. Changes in cellular
activities could also be monitored by isolation of primary cells and/or intact mitochondria
from various tissues under different conditions. This would signify how Cytc
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phosphorylation maintains healthy conditions of tissues and how it is affected by stress,
thereby affecting the protein’s functions.
Third, if more than one site is phosphorylated in the protein purified from the
same tissue, then double as well as single phospho-mimetic mutant proteins can be
prepared, and the activities can be compared to one another, as well as the wild type
protein. This will suggest if phosphorylation on one particular site lead to altered activities
or if it is a combination of all the existing phosphorylations.
Fourth, deciphering the different kinases and phosphatases within the
mitochondrial intermembrane space targeting the Cytc protein and phosphorylating it on
different sites will suggest the combination of signaling pathways that converge on
mitochondria of a specific tissue at a time, and result in Cytc phosphorylation.
Experiments performed to find out if any one site affected the protein’s function more than
the other will indicate which signaling pathway has a stronger impact on mitochondrial
functions through Cytc phosphorylation.
Fifth, to follow changes in phosphorylation status of Cytc under various stressful
conditions, antibodies can be raised against Cytc phosphorylated at a particular site.
These phospho-site-specific antibodies can be used to track changes in the levels of
phosphorylation on the particular site within tissue-sections or purified proteins.
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Mammalian cytochrome c (Cytc), the only water-soluble component of the

electron transfer chain plays a key role in cellular life and death decisions, functioning as
an electron carrier in the electron transport chain (ETC) and as a trigger of apoptosis
when released. However, its regulation is not well understood. Modified Cytc purification
techniques that leads to the purification of the protein maintaining the physiological
phosphorylation status within the particular organ depicts a novel means of regulation via
cell signaling pathways that is yet to be studied in detail. Four phosphorylation sites have
been mapped on mammalian Cytc till date, and two of them have been studied
functionally, demonstrating that both respiration and apoptosis are under the control of
signaling pathways that have yet to be identified. Our previous studies showed that Cytc
is phosphorylated on Tyr48 in liver, on Tyr97 in heart, and here we show that Cytc is
phosphorylated on Thr28 in kidneys. Our study shows that phosphorylation of Cytc on
Thr28 causes an inhibition of respiration in the reaction with cytochrome c oxidase. Thr28
is located at a central position near the heme crevice as we show here by high resolution

92

crystallography. Introduction of Thr28Glu phosphomimetic Cytc into Cytc knockout cells
shows that intact cell respiration, mitochondrial membrane potential (m), and ROS
levels are reduced compared to wild-type. Finally, Thr28 phosphorylation is mediated by
AMP kinase, which colocalizes with Cytc to the intermembrane space. We conclude that
Cytc phosphorylation leads to regulation of ETC flux via ‘controlled respiration,’
preventing m hyperpolarization, a known cause of ROS and a trigger of apoptosis.
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